Method and device for repairing cartilage defects
Delivering MAI implants using arthroscopic techniques solves the problems of infection risks and long recovery times associated with open surgery, enabling the delivery of support matrix and treatment of cartilage defects through minimally invasive cell seeding under arthroscopy.
Patent Information
- Application Number
- CN202380035184.2
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Priority Date
- 2022-03-04
- Filing Date
- 2023-03-03
- Publication Date
- 2024-11-29
AI Technical Summary
Existing matrix-induced autologous chondrocyte implantation (MACI) techniques typically require open surgery, which carries risks of infection, long recovery times, and increased pain, and makes it difficult to effectively deliver cells to the defect site at the joint junction.
Arthroscopic techniques are used to deliver MAI implants, with arthroscopic tools and kits used for cartilage defect preparation and cell seeding to support matrix implantation, reducing invasiveness and maintaining cell viability, including the use of cannula assemblies, cutting tools, and matrix shuttle delivery devices.
This technology enables arthroscopic delivery of cell seeding support matrix with minimal invasiveness, reducing the risk of infection and recovery time while maintaining cell viability, making it suitable for treating cartilage and osteochondral defects.
Smart Images

Figure CN119053293A_ABST
Abstract
Description
[0001] CROSS-REFERENCE TO RELATED APPLICATIONS
[0002] This application claims priority to U.S. Provisional Application No. 63 / 316,920, filed on March 4, 2022, entitled “Methods and Devices for Repairing Cartilage Defects,” the contents of which are incorporated herein by reference in their entirety. Background Art
[0003] Cartilage and osteochondral damage (such as focal damage in the load-bearing area of knee cartilage) can greatly increase the risk of osteoarthritis. This type of damage often occurs due to, for example, trauma, participation in sports, osteochondritis dissecans. The spontaneous repair ability of cartilage damage is extremely small, partly because the blood supply of cartilage tissue is limited. The treatment of damaged cartilage needs to replace the defective cartilage with healthy cartilage; autologous chondrocyte implantation strategies have been described to complete this replacement (Brittberg et al., Clin.Orthopaed.Red.Res. (1999) 367S: S147-S155). In this type of surgery, chondrocytes are collected from the patient, expanded in cell culture to increase the number of chondrocytes, and then implanted back into the patient's injury site.
[0004] Newer studies have improved autologous implantation by inoculating amplified autologous cells on a matrix in a process called matrix-induced autologous chondrocyte implantation (MACI) (Basad et al., cited in: Hendrich et al. Cartilage Surgery and Future Perspectives, Thieme Verlag, 49-56 (2003)). The MACI process has been further improved to allow implantation of allogeneic cells, thereby reducing the total number of necessary surgeries experienced by patients. However, MACI surgery is typically performed via a mini-arthrotomy, which is an open surgical technique that typically carries a greater risk of infection, longer recovery time, and increased pain for the patient compared to less invasive surgical methods. In addition, the defects presented by many patients are easily treated via minimally invasive surgery. Summary of the invention
[0005] The present disclosure provides improved matrix-induced autologous chondrocyte implantation (MACI) technology. For example, the present disclosure provides, among other things, technology for arthroscopic delivery of MACI implants; in some embodiments, the technology provided is characterized in that they achieve delivery characterized by a cell viability level comparable to that observed under non-arthroscopic delivery. The advantages of the provided method include, for example, that arthroscopic delivery is far less invasive than open surgical strategies typically used to administer MACI implants. Therefore, the technology provided represents and embodies further improvements relative to arthroscopic MACI technology (tools, methods, and kits) for treating tissue defects (e.g., cartilage defects and other types of defects).
[0006] In some embodiments, the present disclosure provides techniques for arthroscopically delivering a composition comprising cells seeded on a matrix surface to a site in an articular joint.
[0007] In some embodiments, the present disclosure provides techniques for treating cartilage defects and / or osteochondral defects.The methods may include implanting a composition including cells seeded on a matrix.
[0008] In some embodiments, the present disclosure provides arthroscopic delivery techniques and methods. In general, the present disclosure provides a set of tools and methods that enable arthroscopic delivery of cell-seeded implants to a prepared cartilage surgical site, thereby effectively repairing cartilage and tissue defects in a less invasive manner than conventional open surgical techniques while maintaining cell viability.
[0009] In some embodiments, the present disclosure provides techniques for arthroscopically preparing a cartilage defect or lesion. The techniques may include one or more surgically sharp cutting tools that define a surgical field in the cartilage and shave, cut, clean, and / or remove the cartilage.
[0010] In some embodiments, before the surgical shuttle delivery device is inserted into a cannula positioned in the surgical site, a composition comprising cells seeded on a matrix (or a cell seeding support matrix) is loaded into the distal end of the surgical shuttle delivery device. The composition can then be released from the surgical shuttle delivery device and delivered into the surgical area previously prepared by a surgically sharp cutting tool.
[0011] In some embodiments, the cells are a monolayer of cells on a membrane.
[0012] In some embodiments, the cell seeding support matrix is cut into a shape and size that closely matches the shape and size of the surgical area prepared by a sharp cutting tool in surgery. The present disclosure provides a method for cutting a cell seeding support matrix using a matrix cutting tool. In some embodiments, the matrix cutting tool can have a sharp blade in a clear shape (for example, oval, circular, square, rectangular, etc.) and along the circumference of the bottom surgery. The matrix cutting tool can be placed on a part of the cell seeding support matrix in a downward manner with the blade side, and by applying a certain force with hands or tools (for example, hammer, mallet, etc.) to press downwards to cut into the cell seeding support matrix. In some embodiments, tools (for example, tweezers, graspers, probes, etc.) can be used or the cut part of the cell seeding support matrix can be manipulated with hands (for example, grab, locate, place, etc.).
[0013] In some embodiments, the present disclosure provides a method of delivering a composition comprising cells seeded on the surface of a matrix (or a cell seeding support matrix) to a defect via arthroscopy, wherein the defect comprises a knee defect in a subject, such as a femoral defect, a trochlear defect, a patellar defect, and / or a tibial defect. In some embodiments, the defect may comprise an ankle defect and / or a shoulder defect. The surface area of the defect may be up to about 4 cm 2 In some embodiments, the method comprises steps performed within a time period extending from surgical incision to surgical closure, wherein the time period does not exceed about 60 minutes. In some embodiments, the defect comprises a cartilage defect. In some embodiments, the cells comprise chondrocytes. In some embodiments, the cells are autologous to the subject. In some embodiments, the cells comprise allogeneic cells.
[0014] In some embodiments, the surgical instrument system includes a sleeve assembly, a composition including cells seeded on the surface of a matrix (or a cell seeding support matrix), and one or more cutting tools for cutting the composition and shaping the composition. The kit may also include one or more of the following tools configured to pass through the sleeve to perform tasks through an arthroscopic method: an arthroscopic measuring tool, an articulated cutting tool, a ring curette, a square curette, a rake curette, a smearing tool, and a matrix shuttle delivery device for transmitting and placing the composition at the surgical site. In some embodiments, the user or operator or surgeon may use other surgical tools and materials during arthroscopic surgery, and the tools and materials may include hemostatic barriers, covering patches, organic glue, scissors, razor blades, scalpels, surgical mallets, tweezers, needles, etc.
[0015] In some embodiments, the cannula assembly may include an obturator, a barrier seal subassembly, and a cannula body. The barrier seal subassembly may be released from the cannula body via a clip or a bump. A flexible barrier seal within the barrier seal subassembly may allow surgical tools to be inserted into the cannula while retaining liquid at the surgical site or in the joint area of the patient. The cannula body may be threaded along its outer surface to increase its stability when installed at the surgical site.
[0016] In some embodiments, the arthroscopic measurement tool may include a handle, a shaft, a flexible ruler, and / or an adjustment knob. The flexible ruler is etched or marked with millimeter-level markings and is connected to the adjustment knob so that sliding the knob longitudinally along the handle causes the ruler to extend or retract, and rotating the knob causes the ruler to rotate to different orientations or angles. The ruler can be used to measure the size of a cartilage defect.
[0017] In some embodiments, the articulated arthroscopic cutting tool may include a handle, a thumb slider, a shaft and / or a curved oval blade with a surgically sharp cutting edge. The sliding thumb slider causes the blade to tilt to different angles relative to the longitudinal axis of the handle and shaft. The blade can be pushed or impacted into the cartilage surrounding the cartilage defect by a surgical mallet to score the cartilage. The scoring of the cartilage forms a clear outline to mark the area where the cartilage should be removed to prepare for implanting cell seeding support matrix. In some embodiments, the curved oval blade made includes various sizes to surround cartilage defects of different sizes. The articulated arthroscopic cutting tool may also be referred to as an arthroscopic cutter.
[0018] In some embodiments, a ring curette may include a handle, a shaft, and / or a circular ring with a surgically sharp cutting edge.
[0019] In some embodiments, a square curette may include a handle, a shaft, and / or a square ring having at least two surgically sharp cutting edges.
[0020] In some embodiments, a rake curette may include a handle, a shaft, and / or a wedge-shaped blade having a surgically sharp cutting edge.
[0021] In some embodiments, the matrix cutter may include an elliptical cylindrical body and / or a sharp edge in the surgery around its bottom circumference. In some embodiments, the matrix cutter may include various sizes to match the size of the curved oval blade in the articulated arthroscopic cutting tool. The matrix cutter is used for cutting the part of the cell-seeding support matrix into a shape that matches the cartilage defect position prepared by the cutting tool when the contact or damage to the cell is minimal.
[0022] In some embodiments, the matrix shuttle delivery device may include a cylindrical body, a plunger and a deployment wing with a finger grip and a tapered delivery end. A portion of the cell seeding support matrix is placed on the matrix shuttle delivery device, which can then be inserted into the sleeve of the surgical site or joint. Pushing the plunger makes the deployment wing protrude at the delivery end to push the cell seeding support matrix away from the matrix shuttle delivery device and onto the defect.
[0023] In some embodiments, the smearing tool may include a cylindrical rod, a smearing swab at one end of the rod and / or a smearing termination at the other end of the rod. The smearing swab may include one or more soft absorbent materials, including polyurethane foam and cotton, and may be used for cleaning and drying the defect. The smearing termination may include silicone or other similar elastic polymer materials. The smearing termination may be used for repositioning cell seeding support matrix and smearing fibrin glue.
[0024] In one aspect, an embodiment of the present invention relates to a cannula assembly, comprising: a cannula body; a barrier seal subassembly, the barrier seal subassembly being disposed proximal to the cannula body, the barrier seal subassembly and the cannula body being coaxially aligned (or longitudinally aligned, or axially aligned); and an obturator, the obturator being coaxially inserted through both the cannula body and the barrier seal subassembly.
[0025] In some embodiments, the cannula body comprises: a hollow cylindrical portion comprising a helical thread wrapped around the entire length of the outer surface of the hollow cylindrical portion; a lip portion at the proximal end of the hollow cylindrical portion, the lip portion comprising a diameter larger than the diameter of the hollow cylindrical portion; two bumps disposed at diametrically opposite positions on the outer edge of the lip portion; and a curved opening at the distal end of the hollow cylindrical portion.
[0026] In some embodiments, the curved opening is marked by a visible outline around the circumference of the curved opening and by two small visible marks at diametrically opposed locations around the curved opening.
[0027] In some embodiments, the cannula body comprises a translucent polycarbonate material.
[0028] In some embodiments, the barrier seal subassembly includes: a barrier top member; a first barrier seal, the first barrier seal including at least one hole; a second barrier seal, the second barrier seal including at least one slit; a third barrier seal, the third barrier seal including at least one slit; and a barrier bottom member. In some embodiments, the barrier top member, the first barrier seal, the second barrier seal, and the third barrier seal are all coaxially aligned (or longitudinally aligned, or axially aligned) and stacked parallel to each other.
[0029] In some embodiments, the baffle top member includes: a circular portion including a circular hole concentrically disposed therein; a plurality of legs extending vertically from a bottom surface of the circular portion and circumferentially distributed around the circular portion; and two notches disposed at diametrically opposite positions around the circular hole.
[0030] In some embodiments, the baffle top member and the baffle bottom member include acrylonitrile butadiene styrene (ABS).
[0031] In some embodiments, the first barrier seal comprises: a circular disk; a circular hole concentrically disposed in the center of the circular disk; and a plurality of smaller circular holes circumferentially disposed around the edge of the disk.
[0032] In some embodiments, the second barrier seal and the third barrier seal each include: a disk; three slits in a radial direction starting from the center of the disk, which are 120 degrees apart from each other; and a plurality of smaller circular holes, the plurality of smaller circular holes being arranged circumferentially around the edge of the disk. In some embodiments, the second barrier seal and the third barrier seal are coaxially stacked one next to the other and rotated so that the slits in each seal do not overlap.
[0033] In some embodiments, the first barrier seal, the second barrier seal, and the third barrier seal all include one of silicone or EPDM rubber.
[0034] In some embodiments, the baffle bottom component includes: a hollow cylindrical portion; a flat circular top portion; a circular hole, which is concentrically arranged in the flat circular top portion; two recesses, which are arranged at diametrically opposite positions around the circular hole; and two baffle release clips, which are arranged at diametrically opposite positions at the distal edge of the hollow cylindrical portion.
[0035] In some embodiments, the baffle top member and the baffle bottom member comprise acrylonitrile butadiene styrene (ABS) or an equivalent.
[0036] In some embodiments, the obturator comprises: a handle portion at the proximal end of the obturator; a shaft portion; and a tip portion at the distal end of the obturator. In some embodiments, the handle portion comprises a rounded dome structure, the dome structure comprising slats of constant thickness arranged parallel and perpendicular to the axial direction, the shaft portion comprises a cylindrical rod connecting the handle portion and the tip portion, the tip portion comprises a conical tip at the distal end and a plurality of support fins, and the handle portion, the shaft portion, and the tip portion are all coaxially aligned (or longitudinally aligned, or axially aligned).
[0037] In some embodiments, the obturator includes: two or more rotational projections protruding from the bottom of the distal side of the handle portion and disposed at diametrically opposite positions; and one or more concave portions in the dome structure of the handle portion.
[0038] In some embodiments, the occluder comprises acrylonitrile butadiene styrene (ABS) or an equivalent.
[0039] In another aspect, an embodiment of the present invention is directed to an arthroscopic surgical method comprising: forming an incision at a joint on a patient's body; inserting a cannula assembly into the incision; measuring a cartilage defect at the joint using an arthroscopic measurement tool inserted through the cannula; preparing a cartilage region around the cartilage defect; and preparing a cell-seeded matrix composition and cutting a portion of the cell-seeded matrix composition using a matrix cutter tool.
[0040] In some embodiments, preparing the cartilage area further comprises: using a cutter tool to score an area in the cartilage surrounding the defect; using one or more cutting tools and scraping tools to clean the scored area to expose the bone surface in a defined area or shape; and using a spreading tool to dry the exposed bone area.
[0041] In some embodiments, the joint site may include one of the medial femoral condyle, the lateral femoral condyle, the patella, or the trochlea.
[0042] In some embodiments, debridement of the scored area further comprises using at least one of a ring curette, a square curette, or a rake curette.
[0043] In another aspect, an embodiment of the present invention is directed to a method for determining the size of a lesion during arthroscopic surgery, comprising: inserting a measuring tool into a sleeve through a barrier seal subassembly; extending a ruler from the measuring tool; measuring at least one dimension of at least one lesion using at least one or more markings on the ruler; retracting the ruler into the measuring tool; and removing the measuring tool from the sleeve and barrier seal subassembly.
[0044] In another aspect, an embodiment of the present invention relates to an arthroscopic measurement probe, comprising: a handle, the handle comprising a top shell and a bottom shell; an adjustment knob; a rotating plug; a positioning pin; a travel arm; a calibrating tube; and a flexible ruler. In some embodiments, the rotating plug, the adjustment knob, the travel arm, the calibrating tube, and the flexible ruler are coaxially connected, and the flexible ruler is disposed through the interior of the calibrating tube.
[0045] In some embodiments, the flexible ruler comprises: a cylindrical rod comprising polyetheretherketone (PEEK); an inner flexible wire comprising nickel titanium alloy (or nitinol); and a plurality of markings distributed along a certain length of the outer surface of the cylindrical rod near the distal end of the cylindrical rod. In some embodiments, the markings comprise thin lines perpendicular to the longitudinal axis of the cylindrical rod and spaced at intervals of 2.5 mm and 5.0 mm.
[0046] In some embodiments, the calibrating tube comprises: a hollow cylindrical tube comprising at least one of stainless steel T304, stainless steel T316, and a split hypodermic tube; two slits disposed at the proximal end of the hollow cylindrical tube and positioned at diametrically opposite positions; a curved portion of the hollow cylindrical tube at the distal end. In some embodiments, the curve comprises a right-angle bend in the tube and an opening in the distal end of the hollow cylindrical tube.
[0047] In some embodiments, the top and bottom shell pieces include acrylonitrile butadiene styrene (ABS) or other similar plastics.
[0048] In another aspect, an embodiment of the present invention relates to a method for scoring cartilage using an articulating arthroscopic cutting tool, comprising: selecting an articulating arthroscopic cutting tool based on a measured size of a defect or damage; removing a baffle sealing subassembly from a sleeve; inserting the articulating arthroscopic cutting tool into the sleeve; using a thumb slider to adjust the bevel angle of the blade; locking the bevel angle; pressing the blade into a cartilage area surrounding the defect; and removing the articulating arthroscopic cutting tool from the sleeve.
[0049] In another aspect, embodiments of the present invention are directed to an articulating arthroscopic cutting tool comprising: a handle; a thumb slider; a linear stator shaft; a curved oval blade connected to the linear stator shaft by an articulating joint; a linear drive shaft connected to the thumb slider; and a linkage connected to both the linear drive shaft and the curved oval blade. In some embodiments, movement of the thumb slider causes the curved oval blade to tilt relative to the linear stator shaft.
[0050] In some embodiments, the handle comprises: an upper shell comprising a ridged semi-cylinder and a rectangular opening, the rectangular opening being cut longitudinally along the ridged semi-cylinder at a distal end closer to the ridged semi-cylinder; and a lower shell comprising a ridged semi-cylinder. In some embodiments, the upper shell and the lower shell are closed together to form a complete cylinder having a circular opening at the distal end, and a plurality of notches are provided on the lower side of the upper shell around the rectangular opening.
[0051] In some embodiments, the upper and lower shells include acrylonitrile butadiene styrene (ABS) or an equivalent plastic.
[0052] In some embodiments, the thumb slider includes: a slider button including a raised top surface at a distal end of the button and a ridged top surface at a proximal end of the button; a slider clamp; and a spring attached to the slider button at one end of the spring and to the slider clamp at another end of the spring, and wherein the spring is vertically disposed between the slider button and the slider clamp. In some embodiments, a cylindrical pin actuated by the slider button can interface with a plurality of notches on the underside of the upper housing.
[0053] In some embodiments, the linear stator shaft includes: a cylindrical rod; a rectangular groove cut longitudinally along the cylindrical rod; a reduced diameter portion along the cylindrical rod near the proximal end of the cylindrical rod; and a ring protruding vertically from the distal end of the cylindrical rod.
[0054] In some embodiments, the linear stator shaft comprises stainless steel type 17-4PH (630) conforming to ASTM A564, UNS S17400.
[0055] In some embodiments, the curved oval blade comprises: an oval ring; at least three cross bars spanning the top surface of the oval ring; a circular ring extending vertically from a first cross bar; two circular rings extending vertically from a second cross bar; and a curved cutting surface along a bottom circumference of the oval ring, wherein the oval ring is thicker at the narrow end of the oval ring, and wherein the curved cutting surface comprises a surgically sharp edge.
[0056] In some embodiments, the curved oval blade comprises stainless steel type 17-4PH (630) conforming to ASTM A564, UNS S17400.
[0057] In another aspect, an embodiment of the present invention is directed to a method for removing cartilage and preparing a surgical site, comprising: inserting a surgical cutting tool selected from at least one of a circular curette, a square curette, or a rake curette into a cannula and a barrier sealing subassembly; using the surgical cutting tool to scrape, cut, clean, and remove cartilage within a cartilage region defined by an articulated arthroscopic cutting tool; removing the cutting tool from the cannula and the barrier sealing subassembly; and repeating the procedure with one or more surgical cutting tools until the cartilage within the cartilage region is completely removed.
[0058] In another aspect, embodiments of the present invention are directed to an annular curette assembly comprising: a handle; a shaft coupled to a distal end of the handle; and an annular curette blade coupled to the distal end of the shaft, wherein the shaft comprises a cylindrical rod having at least two bends such that the distal end of the shaft has an axis that is parallel and eccentric relative to a major longitudinal axis of the shaft, and wherein the annular curette blade comprises at least one surgically sharp edge.
[0059] In some embodiments, the shaft includes: a cylindrical rod; a flat portion at the proximal end of the cylindrical rod, the flat portion being used to attach within a handle; a first bend, the first bend being in the cylindrical rod near the distal end of the rod such that the rod axis is tilted away from the main longitudinal axis of the cylindrical rod; a second bend, the second bend being further in the cylindrical rod toward the distal end of the rod such that the rod axis is tilted to be parallel to the main longitudinal axis of the cylindrical rod and eccentrically positioned relative to the main longitudinal axis; a cylindrical portion of reduced diameter near the distal end of the rod; and a recessed opening having a flat inner surface at the distal end of the shaft.
[0060] In some embodiments, the annular curette blade comprises: a ring in the shape of a hollow right conical frustum; a rounded edge around the larger circumference of the ring; a surgically sharp edge around the larger circumference of the ring; a cylindrical connecting shaft, the cylindrical connecting shaft being arranged radially outward at the outer wall of the ring; and a cylindrical welding shaft, the cylindrical welding shaft being arranged coaxially with the connecting shaft. In some embodiments, the diameter of the cylindrical welding shaft is smaller than the cylindrical connecting shaft.
[0061] In some embodiments, the shaft and annular curette blade comprise stainless steel type 17-4PH (630) conforming to ASTM A564 or equivalent, and / or UNS S17400.
[0062] In some embodiments, the handle includes: a cylindrical body; a plurality of ridges on the outer side surfaces and bottom surfaces of the cylindrical body, wherein the plurality of ridges are arranged perpendicular to the longitudinal axis of the cylindrical body; a flat surface along the top surface of the cylindrical body; and a circular opening in the distal end of the cylindrical body.
[0063] In some embodiments, the handle comprises acrylonitrile butadiene styrene (ABS) or an equivalent.
[0064] In another aspect, embodiments of the present invention are directed to a square curette assembly comprising: a handle; a shaft coupled to a distal end of the handle; and a square curette blade coupled to the distal end of the shaft. In some embodiments, the shaft comprises a cylindrical rod having at least two bends such that the distal end of the shaft has an axis that is parallel and eccentric relative to a major longitudinal axis of the shaft, and the square curette blade comprises at least two surgically sharp edges at the distal end of the square curette blade.
[0065] In some embodiments, a square curette blade comprises: a ring in the shape of a hollow rounded rectangular prism; at least two surgically sharp edges at the top edge and the bottom edge of the ring at the distal side of the rectangular prism; a cylindrical connecting shaft, the cylindrical connecting shaft being arranged outwardly at the outer wall of the ring and opposite to the two surgically sharp edges; and a cylindrical welding shaft, the cylindrical welding shaft being arranged coaxially with the connecting shaft. In some embodiments, the diameter of the cylindrical welding shaft is smaller than that of the connecting shaft.
[0066] In some embodiments, the shaft and square curette blade comprise stainless steel type 17-4PH (630) conforming to ASTM A564 or equivalent, or UNS S17400.
[0067] In another aspect, embodiments of the present invention are directed to a rake curette assembly comprising: a handle; a rake shaft coupled to a distal end of the handle; and a rake head blade coupled to the distal end of the shaft. In some embodiments, the rake shaft comprises a cylindrical rod that tapers to a smaller diameter near the distal end of the shaft, and the rake head blade comprises a tapered wedge having at least one surgically sharp edge.
[0068] In some embodiments, the rake shaft comprises: a cylindrical shaft; a flat portion at the proximal end of the shaft, the flat portion being adapted to be attached within a handle; and a tapered portion. In some embodiments, the diameter of the cylindrical shaft gradually decreases toward the distal end of the rake shaft, and the rake further comprises a cylindrical weld shaft of further reduced diameter, the cylindrical weld shaft being coaxially disposed with the tapered portion of the rake shaft.
[0069] In some embodiments, a rake head blade includes a wedge-shaped body having a decreasing thickness as the depth increases, a rounded top portion having a cylindrical opening for welding, and a surgically sharp edge at an end of the wedge-shaped body.
[0070] In some embodiments, the shaft and rake head blade comprise stainless steel type 17-4PH (630) conforming to ASTM A564 or equivalent, or UNS S17400.
[0071] In another aspect, embodiments of the invention are directed to a method for cutting a cell-seeded support matrix, comprising: selecting a matrix cutter size to match a surgical site prepared by cutting and removing cartilage surrounding a defect or damage; placing a cell-seeded support matrix on a cutting mat with cells on the matrix facing upward; placing a selected matrix cutter onto the cell-seeded support matrix with a surgically sharp edge facing downward; applying a downward force on the top side of the matrix cutter using at least one of a hand, a mallet, a hammer, or other tool; and removing the matrix cutter and removing the uncut portion of the cell-seeded support matrix.
[0072] In another aspect, embodiments of the present invention are directed to a matrix cutter comprising: an elliptical cylindrical body; an inner bore shaped as a stadium-shaped hole aligned parallel to a semi-major axis of the elliptical cylindrical body and longitudinally aligned parallel to a longitudinal axis of the elliptical cylindrical body; a flat top surface of the elliptical cylindrical body; at least two flat gripping notches at opposite outer sides of the elliptical cylindrical body; and a surgically sharp edge around a bottom circumference of the elliptical cylindrical body.
[0073] In some embodiments, the matrix cutter comprises stainless steel type 17-4PH (630) conforming to ASTM A564 and / or UNS S17400.
[0074] In another aspect, embodiments of the present invention relate to a method for delivering and implanting a cell-seeded support matrix into a prepared cartilage surgical site, comprising: stopping fluid flow and removing a barrier seal subassembly at the surgical site; using a first swab to clean and dry the surgical site, where cartilage surrounding a lesion or defect was previously cut and removed; using forceps to grasp a piece of the previously cut cell-seeded support matrix by grasping the edges of the matrix; placing the cell-seeded support matrix across the delivery tip of a matrix shuttle delivery device so that the matrix is within the contour at the delivery tip and the matrix is positioned within the contour of the delivery tip; The cell-containing side is facing away from the delivery end; using a second smear swab to apply fibrin glue to the surgical site; inserting the matrix shuttle delivery device into the cannula at the surgical site; depressing the plunger on the matrix shuttle device to extend at least one antenna from the delivery end of the matrix shuttle device to push the cell-seeding support matrix out and onto the surgical site; removing the matrix shuttle device from the cannula; if necessary, using a third smear swab to reposition the cell-seeding support matrix; and using a fourth smear swab to apply fibrin glue around the edge of the cell-seeding support matrix at the surgical site.
[0075] In another aspect, an embodiment of the present invention is directed to a matrix shuttle delivery device comprising: a shuttle body, wherein the shuttle body comprises a substantially hollow cylinder; a delivery tip at the distal end of the shuttle body; a plunger, which is longitudinally disposed within the shuttle body and protrudes outward from the proximal end of the shuttle body; at least two deployment wings, which are disposed inside the delivery tip and attached to the plunger; and at least two holes on the distal surface of the delivery tip; wherein pushing the plunger longitudinally into the shuttle body causes the at least two deployment wings to protrude to the outside through the at least two holes of the delivery tip.
[0076] In some embodiments, the matrix shuttle device also includes a spring longitudinally arranged inside the shuttle body and attached to the plunger. In some embodiments, the matrix shuttle device also includes one or more finger grips arranged at the proximal end of the shuttle body. In some embodiments, one or more finger grips each include a rod, which is connected to the outer surface of the shuttle body at one end and extends radially outward away from the shuttle body, wherein the distal end of each rod is bent to adapt to the user's finger.
[0077] In some embodiments, the delivery tip comprises: a cylindrical portion connected to the shuttle body at the proximal end of the delivery tip; a tapered portion comprising two inclined sides that converge to a flat surface at the distal end of the delivery tip; and a contour flange around the distal end of the delivery tip, the contour flange comprising an elliptical or oblong shape, wherein the centerline of the contour flange is substantially parallel to the flat surface at the distal end of the delivery tip. In some embodiments, at least two holes are each positioned on the two inclined sides of the delivery tip so that when the deployment wings are extended, the line connecting the rounded ends of the deployment wings is substantially perpendicular to the flat surface at the distal end of the delivery tip. In some embodiments, at least two holes each comprise a diameter larger than the diameter of each of the at least two deployment wings.
[0078] In some embodiments, the deployment wing comprises: a U-shaped body; at least two wing arms, the at least two wing arms comprising cylindrical rods extending in parallel from the U-shaped body and bending outwardly away from the U-shaped body; at least two rounded tips at the distal ends of the at least two wing arms; and a circular hole at the proximal bottom of the U-shaped body. In some embodiments, the deployment wing comprises at least one member of the group consisting of: silicone, ethylene propylene diene monomer (EPDM) rubber, plastic, and a flexible polymer material.
[0079] In some embodiments, the plunger comprises: a cylindrical body; a flat disk portion at the proximal end of the cylindrical body; and a recessed portion having a protruding pin at the proximal end of the cylindrical body, wherein the protruding pin comprises a small cylinder disposed perpendicular to the longitudinal axis of the cylindrical body and a rounded knob having a diameter greater than the diameter of the small cylinder. In some embodiments, the protruding pin of the plunger passes through a circular hole at the proximal bottom of the U-shaped body of the deployment wing.
[0080] In some embodiments, the plunger and the shuttle body include at least one of acrylonitrile butadiene styrene (ABS) or plastic. In some embodiments, the shuttle body, the delivery tip, and the finger grip are formed to converge to form two continuous identical shells of the matrix shuttle delivery device. In some embodiments, when the plunger is released, the spring retracts the at least two deployment wings into the at least two holes.
[0081] In another aspect, an embodiment of the present invention relates to a matrix shuttle delivery device, comprising: a shuttle body, wherein the shuttle body comprises a substantially hollow cylinder; a delivery tip at the distal end of the shuttle body, the delivery tip comprising: a cylindrical portion, the cylindrical portion connected to the shuttle body at the proximal end of the delivery tip; a tapered portion, the tapered portion comprising two inclined sides, the two inclined sides converging to a flat surface at the distal end of the delivery tip; and a contour flange spanning the top and distal end of the delivery tip, the contour flange comprising an elliptical or oblong shape; a plunger, the plunger being longitudinally disposed within the shuttle body and protruding outward from the proximal end of the shuttle body, the plunger comprising: a cylindrical body; a flat disk portion at the proximal end of the cylindrical body; and a recessed portion having a protruding pin at the proximal end of the cylindrical body, wherein the protruding pin comprises a small cylinder disposed perpendicular to the longitudinal axis of the cylindrical body and a rounded knob having a diameter larger than the diameter of the small cylinder.
[0082] In some embodiments, the matrix shuttle delivery device also includes: at least two deployment wings, the at least two deployment wings are disposed inside the delivery tip and attached to the plunger, the deployment wings include: a U-shaped body; at least two wing arms, the at least two wing arms include cylindrical rods extending in parallel from the U-shaped body and bending outward away from the U-shaped body; at least two rounded tips at the distal ends of the at least two wing arms; a circular hole at the proximal bottom of the U-shaped body; and one or more finger grips, the one or more finger grips are disposed at the proximal end of the shuttle body, the device also includes: at least two holes, each hole is positioned on one of the two inclined sides of the delivery tip; and a spring, the spring is longitudinally disposed inside the shuttle body and attached to the plunger, wherein pushing the plunger longitudinally into the shuttle body causes the at least two deployment wings to leave the at least two holes of the delivery tip, and wherein when the plunger is released, the spring causes the at least two deployment wings to retract into the at least two holes.
[0083] In another aspect, the present disclosure relates to an arthroscopic surgical method for repairing a cartilage defect, comprising: forming an incision at a joint near the cartilage defect on a patient's body; inserting a sleeve assembly into the incision; using an arthroscopic measurement tool inserted through the sleeve to measure the cartilage defect at the joint; preparing a cartilage area around the cartilage defect; preparing a cell-seeded matrix composition and using a matrix cutter tool to cut a portion of the cell-seeded matrix composition to match the shape of the prepared cartilage area; placing the portion of the cell-seeded matrix composition across a delivery tip of a matrix shuttle delivery device; inserting the matrix shuttle delivery device through the sleeve; pressing a plunger on the matrix shuttle delivery device to extend at least two deployment wings from the delivery tip, thereby pushing the portion of the cell-seeded matrix composition away from the delivery tip and onto the prepared cartilage area; and removing the matrix shuttle delivery device from the sleeve.
[0084] In some embodiments, preparing the cartilage region includes: defining a cartilage region surrounding the cartilage defect using a first cutting tool; and scraping, cutting, clearing and / or removing cartilage within the cartilage region defined by the first cutting tool using one or more additional surgical cutting tools.
[0085] In some embodiments, the cell-seeded matrix composition includes chondrocytes seeded on one side of a bioresorbable matrix, and wherein the side of the matrix having the chondrocytes faces away from the delivery tip of the matrix shuttle delivery device.
[0086] In some embodiments, the method further comprises: applying fibrin glue to the prepared cartilage before delivering the cell-seeded matrix composition; applying fibrin glue around the edges of the cell-seeded matrix composition after delivering the cell-seeded matrix composition to the prepared cartilage; removing the cannula from the incision; and closing the incision surgically.
[0087] In another aspect, embodiments of the present invention relate to an application tool comprising: a cylindrical rod; an application swab, the application swab being attached to one end of the cylindrical rod by an adhesive; and an application tip, the application tip being attached to the other end of the cylindrical rod by an adhesive. In some embodiments, the cylindrical rod is made of or includes a plastic material, the application swab includes cotton, polyurethane foam, and / or other similar soft absorbent materials, and the application tip includes soft silicone or other similar compliant materials. BRIEF DESCRIPTION OF THE DRAWINGS
[0088] When with Figure 1 The present teachings described herein will be more fully understood from the following description of various illustrative embodiments when read together. It should be understood that the drawings described below are for illustration purposes only and are not intended to limit the scope of the present teachings in any way.
[0089] Figure 1 A schematic diagram of a method of performing arthroscopic surgery according to aspects of an embodiment of the present invention is shown.
[0090] Figure 2 A shows a view of an exemplary arthroscopic surgical procedure according to aspects of embodiments of the present invention.
[0091] Figure 2 B shows a view of an exemplary arthroscopic surgical procedure according to aspects of embodiments of the present invention.
[0092] Figure 2 C shows a view of an exemplary arthroscopic surgical procedure according to aspects of embodiments of the present invention.
[0093] Figure 2 D shows a view of an exemplary arthroscopic surgical procedure according to aspects of embodiments of the present invention.
[0094] Figure 2 E shows a view of an exemplary arthroscopic surgical procedure according to aspects of embodiments of the present invention.
[0095] Figure 2 F shows a view of an exemplary arthroscopic surgical procedure according to aspects of embodiments of the present invention.
[0096] Figure 3 A schematic diagram of a method of using a cannula assembly during an arthroscopic surgical procedure is shown in accordance with aspects of an embodiment of the present invention.
[0097] Figure 4 A perspective view of a cannula assembly according to aspects of an embodiment of the present invention is shown.
[0098] Figure 5 The manner in which the obturator and baffle subassemblies fit together according to aspects of embodiments of the present invention are shown.
[0099] Figure 6 A perspective view of a cannula body according to aspects of an embodiment of the present invention is shown.
[0100] Figure 7 A side view of a cannula body according to aspects of an embodiment of the present invention is shown.
[0101] Figure 8 A perspective view of a cannula body according to aspects of an embodiment of the present invention is shown.
[0102] Fig. 9 A perspective view of a baffle seal subassembly according to aspects of an embodiment of the present invention is shown.
[0103] Fig.10 A perspective exploded view of components of a baffle seal subassembly according to aspects of embodiments of the present invention is shown.
[0104] Fig.11 A perspective view of a barrier seal having slits according to aspects of embodiments of the present invention is shown.
[0105] Fig.12 A perspective view of a baffle seal having an aperture according to aspects of an embodiment of the present invention is shown.
[0106] Fig.13 A perspective view of an occluder according to aspects of an embodiment of the present invention is shown.
[0107] Fig.14A side view of an occluder according to aspects of an embodiment of the present invention is shown.
[0108] Fig.15 Illustrations of an obturator and barrier seal subassembly positioned adjacent a cannula inserted into an incision at a joint are shown in accordance with aspects of embodiments of the present invention.
[0109] Fig.16 A schematic diagram of a method of using an arthroscopic measurement probe according to aspects of an embodiment of the present invention is shown.
[0110] Fig.17 A perspective view of an arthroscopic measurement probe assembly according to aspects of an embodiment of the present invention is shown.
[0111] Fig.18 A perspective exploded view of portions of an arthroscopic measurement probe assembly is shown in accordance with aspects of an embodiment of the present invention.
[0112] Fig.19 A measuring stick for an arthroscopic measurement probe according to aspects of embodiments of the present invention is shown.
[0113] Fig. 20 A tube for an arthroscopic measurement probe according to aspects of embodiments of the present invention is shown.
[0114] Fig.21 A perspective view of an arthroscopic measurement probe assembly is shown with arrows indicating motion and showing an extended measuring ruler in accordance with aspects of an embodiment of the present invention.
[0115] Fig. 22 A schematic diagram of a method of using an articulating arthroscopic cutting tool during an arthroscopic surgical procedure is shown in accordance with aspects of embodiments of the present invention.
[0116] Fig.23 A perspective view of an articulating arthroscopic cutting tool assembly according to aspects of an embodiment of the present invention is shown.
[0117] Fig.24 A perspective view of the distal end of an articulating arthroscopic cutting tool assembly is shown in accordance with aspects of embodiments of the present invention.
[0118] Fig.25 Shown is a perspective exploded view of portions of an articulating arthroscopic cutting tool assembly in accordance with aspects of embodiments of the present invention.
[0119] Fig.26 A perspective view of a handle of an articulating arthroscopic cutting tool assembly is shown in accordance with aspects of embodiments of the present invention.
[0120] Fig. 27A perspective view of a linear stator shaft of an articulating arthroscopic cutting tool assembly is shown in accordance with aspects of embodiments of the present invention.
[0121] Fig.28 A perspective view of the distal end of an articulating arthroscopic cutting tool assembly is shown in accordance with aspects of embodiments of the present invention.
[0122] Fig.29 A perspective view of a blade of an articulating arthroscopic cutting tool assembly according to aspects of embodiments of the present invention is shown.
[0123] Fig.30 A schematic diagram of a method for preparing a surgical site during arthroscopic surgery using at least one of a ring curette, a square curette, or a rake curette is shown in accordance with aspects of embodiments of the present invention.
[0124] Fig.31 An annular curette assembly according to aspects of embodiments of the present invention is shown.
[0125] Fig.32 A shaft that may be used with a ring curette assembly or a square curette assembly according to aspects of embodiments of the present invention is shown.
[0126] Fig.33 A perspective view of an annular curette blade according to aspects of an embodiment of the present invention is shown.
[0127] Fig.34 A handle assembly that may be used with a ring curette, a square curette, or a rake curette according to aspects of embodiments of the present invention is shown.
[0128] Fig.35 A square curette assembly according to aspects of embodiments of the present invention is shown.
[0129] Fig.36 A square curette blade for a square curette assembly according to aspects of embodiments of the present invention is shown.
[0130] Fig.37 A rake curette assembly according to aspects of embodiments of the present invention is shown.
[0131] Fig.38 A rake shaft for a rake curette assembly according to aspects of embodiments of the present invention is shown.
[0132] Fig.39 A rake head blade for a rake curette assembly according to aspects of embodiments of the present invention is shown.
[0133] Fig.40A schematic diagram of a method of preparing a cell-seeded matrix composition for use during arthroscopic surgery is shown in accordance with aspects of embodiments of the present invention.
[0134] Fig.41 A shows a view illustrating the preparation of a cell seeding support matrix composition according to aspects of embodiments of the present invention.
[0135] Fig.41 B shows a view illustrating the preparation of a cell seeding support matrix composition according to aspects of embodiments of the present invention.
[0136] Fig.41 C shows a view illustrating the preparation of a cell seeding support matrix composition according to aspects of embodiments of the present invention.
[0137] Fig.42 A top-down perspective view of a matrix cutter according to aspects of embodiments of the present invention is shown.
[0138] Fig.43 A bottom-up perspective view of a matrix cutter according to aspects of embodiments of the present invention is shown.
[0139] Fig.44 Schematic diagrams of methods of implanting a cell-seeded matrix composition according to aspects of embodiments of the present invention are shown.
[0140] Fig.45 A perspective view of a matrix shuttle delivery device with deployment wings extended is shown in accordance with aspects of embodiments of the present invention.
[0141] Fig.46 A perspective view of a matrix shuttle delivery device with deployment wings retracted is shown in accordance with aspects of embodiments of the present invention.
[0142] Fig.47 A side view of a delivery tip of a matrix shuttle delivery device with a cell seeding support matrix positioned across the delivery tip is shown in accordance with aspects of embodiments of the present invention.
[0143] Fig.48 A side view of a matrix shuttle delivery device is shown with deployment wings extended and plunger squeezed to deliver a cell-seeded support matrix in accordance with aspects of embodiments of the present invention.
[0144] Fig.49 Shown is a perspective exploded view of a portion of a matrix shuttle delivery device according to aspects of embodiments of the present invention.
[0145] Fig.50 A perspective view of a deployment wing for use with a matrix shuttle delivery device is shown in accordance with aspects of embodiments of the present invention.
[0146] Fig.51 A perspective view of an applicator tool according to aspects of an embodiment of the present invention is shown.
[0147] Fig.52 A schematic diagram of an arthroscopic surgical method for repairing a cartilage defect in accordance with aspects of an embodiment of the present invention is shown.
[0148] definition
[0149] As used herein, when used to refer to a value, the term "about" refers to a value similar to the value mentioned in the context. Generally speaking, those skilled in the art who are familiar with the context should understand the relevant degree of difference covered by "about" in this context. For example, in some embodiments, the term "about" can be included in 25%, 20%, 19%, 18%, 17%, 16%, 15%, 14%, 13%, 12%, 11%, 10%, 9%, 8%, 7%, 6%, 5%, 4%, 3%, 2%, 1% or a smaller range of values in the reference value.
[0150] As used herein, the term "adult" refers to a person who is eighteen years of age or older. In some embodiments, an adult weighs in the range of about 90 pounds to about 250 pounds.
[0151] As used herein, the term "associated with" refers to the association of two events or entities when the presence, level, and / or form of one event or entity is associated with another. For example, if the presence, level, and / or form of a particular entity (e.g., a polypeptide, a gene signature, a metabolite, a microorganism, etc.) is associated with the incidence and / or susceptibility of a disease, disorder, or condition (e.g., in a related population), the particular entity is considered to be associated with a particular disease, disorder, or condition. In some embodiments, if two or more entities interact directly or indirectly so that they are physically close to each other and / or remain physically close, they are physically "associated" with each other. In some embodiments, two or more entities that are physically associated with each other are covalently connected to each other; in some embodiments, two or more entities that are physically associated with each other are not covalently connected to each other, but are non-covalently associated, such as by hydrogen bonding, van der Waals interactions, hydrophobic interactions, magnetism, and combinations thereof.
[0152] As used herein, the term "biocompatible" refers to materials that, when placed in contact with living tissue (e.g., in vivo), do not cause significant damage to such tissue. In certain embodiments, materials are "biocompatible" if they are not toxic to cells. In certain embodiments, materials are "biocompatible" if addition of the material to cells in vitro does not result in significant cell death, and / or administration of the material in vivo does not induce significant inflammation or other such side effects.
[0153] As used herein, the term "chondrocyte" or "cartilage cell" refers to a cell capable of expressing the biochemical marker properties of a chondrocyte, including but not limited to type II collagen, aggrecan, chondroitin sulfate and / or keratin sulfate. In some embodiments, a chondrocyte or cartilage cell expresses the morphological marker properties of a smooth muscle cell, including but not limited to a circular morphology in vitro. In some embodiments, a chondrocyte or cartilage cell can secrete type II collagen in vitro. In some embodiments, a chondrocyte or cartilage cell can secrete aggrecan in vitro. In some embodiments, a chondrocyte or cartilage cell can produce a tissue or matrix having the hemodynamic properties of cartilage in vitro.
[0154] As used herein, the term "ex vivo" refers to events that occur in tissues that are outside of or removed from multicellular organisms, such as humans and non-human animals. In the context of cell-based systems, the term can be used to refer to events that occur in isolated tissue samples taken from an organism (as opposed to, for example, in vivo systems).
[0155] As used herein, the term "extracellular" refers to molecules, substances or processes located or present outside a cell or cell population. In the context of cell-based systems, the term can be used to refer to natural biological substances (e.g., "extracellular matrix") found adjacent to and outside a cell or cell population.
[0156] As used herein, the term "defect" refers to a tissue abnormality or defect, such as in a subject's joint. In some embodiments, the defect is a cartilaginous defect. In some embodiments, the defect is a tissue defect in an articular joint (e.g., a knee joint). In some embodiments, the defect is a chondral defect. In some embodiments, the defect is an osteochondral defect. In some embodiments, the size of the defect may range from about 0.1 to about 10 cm. 2 In some embodiments, the size of the defect may be greater than 10 cm 2 .
[0157] As used herein, the term "density" refers to the average number of substances (e.g., cells or another object) per unit area of volume. In some embodiments, density is cell density, i.e., the number of cells per unit surface area. In some embodiments, the average density is approximated by dividing the number of cells inoculated by the macroscopic surface area of the surface on which they grow. In some embodiments, the surface is two-dimensional. In some embodiments, the surface is three-dimensional.
[0158] As used herein, the term "in vitro" refers to events that occur in an artificial environment (eg, in a test tube or reaction vessel, in cell culture, etc.) rather than in vivo in a multicellular organism.
[0159] As used herein, the term "in vivo" refers to events that occur within multicellular organisms (such as humans and non-human animals). In the context of cell-based systems, the term can be used to refer to events that occur within living cells (as opposed to, for example, in vitro systems).
[0160] As used herein, the term "culture medium" refers to a component that supports the growth or maintenance of cells in culture. In some embodiments, this may include traditional liquid cell culture medium and additional factors. In some embodiments, additional factors may include, for example, serum, antibiotics, growth factors, pharmacological agents, buffers, pH indicators, etc. In some embodiments, culture medium may be used in the process of separating cells (e.g., chondrocytes and / or chondrocyte precursors) from tissue samples (e.g., cartilage samples). In some embodiments, tissue is mechanically destroyed (e.g., minced, chondrocytes, blended), and then combined with culture medium. In some embodiments, culture medium includes enzymes (e.g., collagenase, protease) to digest tissue and release cells.
[0161] As used herein, the term "conditioned medium" refers to medium that has been contacted with cells to allow for changes in the composition of the medium, such as by the uptake or release of one or more metabolites, nutrients, or factors.
[0162] As used herein, the term "patient" refers to any organism to which the provided composition is or can be applied, for example, for the purpose of experiment, diagnosis, prevention, beauty and / or treatment. Typical patients include animals (e.g., mammals, such as mice, rats, rabbits, non-human primates and / or humans). In some embodiments, the patient is a human. In some embodiments, the patient suffers from or is susceptible to one or more disorders or diseases. In some embodiments, the patient shows one or more symptoms of a disorder or disease. In some embodiments, the patient has been diagnosed with one or more disorders or diseases. In some embodiments, the patient is receiving or has received certain therapies to diagnose and / or treat a disease, disorder or disease.
[0163] As used herein, the term "seeding" refers to a process or step in which cells are contacted with a support matrix and adhered (with or without an adhesive) to a support matrix (e.g., a collagen membrane) over a period of time. The seeded cells can split and / or differentiate on the support matrix. In some embodiments, the cells are seeded on the support matrix before being implanted in a subject.
[0164] As used herein, the term "subject" refers to an organism, typically a mammal (e.g., a human, including prenatal human forms in some embodiments). In some embodiments, the subject suffers from a relevant disease, disorder, or illness. In some embodiments, the subject is susceptible to a disease, disorder, or illness. In some embodiments, the subject shows one or more symptoms or characteristics of a disease, disorder, or illness. In some embodiments, the subject does not show any symptoms or characteristics of a disease, disorder, or illness. In some embodiments, the subject is a person with one or more characteristics, characterized by a susceptibility to a disease, disorder, or illness or a risk of a disease, disorder, or illness. In some embodiments, the subject is a patient. In some embodiments, the subject is an individual to whom diagnosis and / or therapy is administered and / or has been administered. In some embodiments, the subject is a donor of a biological sample, tissue, and / or material.
[0165] As used herein, the term "substantially" refers to the qualitative condition of a characteristic or property of interest that exhibits an overall or near-overall range or degree. One of ordinary skill in the biological field will appreciate that biological and chemical phenomena rarely, if ever, reach completeness and / or proceed to completeness or achieve or avoid absolute results. Therefore, the term "substantially" is used herein to embody the potential lack of completeness inherent in many biological and chemical phenomena.
[0166] As used herein, the term "substantially free of endotoxin" means that the endotoxin level of the composition per dose is below the level allowed by the FDA for biologics (i.e., total endotoxin is 5 EU / kg body weight per hour, 350 EU per total dose for an average 70 kg human).
[0167] As used herein, the term "substantially free of mycoplasma and / or microbial contamination" refers to a negative reading of a generally accepted contamination test known to those skilled in the art. For example, mycoplasma contamination is determined by subculturing a product sample in a broth medium and distributing the culture on an agar plate at 37°C on the 1st, 3rd, 7th and 14th day using appropriate positive and negative controls. In some embodiments, a real-time PCR method is used to determine mycoplasma contamination. The appearance of the product sample is compared with the positive and negative controls under a 100x microscope. In addition, the presence of mycoplasma contamination can be detected by inoculating an indicator cell culture, incubating the indicator cell culture for 3 days and 5 days, and then inspecting it under an epifluorescence microscope at 600 times using a DNA-binding fluorescent dye. If the agar and / or broth medium procedure and the indicator cell culture procedure do not show evidence of mycoplasma contamination, the composition is considered to be satisfactory. In some embodiments, the assay that can be used to assess the level of microbial contamination can be or include the United States Pharmacopeia (USP) direct transfer method. This involves inoculating the sample into a tube containing tryptic soy broth medium and liquid thioglycollate medium. During the specified incubation period (e.g., 14 days), the tubes are regularly observed for cloudy appearance (turbidity). A turbid appearance in either medium on any day indicates contamination, while a clear appearance (no growth) indicates that the composition can be considered to be essentially free of contamination. In some embodiments, an alternative to the approved USP method is used to detect microbial contamination, such as the BacT / ALERT test using different medium formulations.
[0168] As used herein, the term "surface area" refers to, for example, the square area of a substrate in cm 2 , or macroscopic surface area.
[0169] As used herein, the term "treatment" (also "treat" or "treating") refers to the administration of a therapy that partially or completely alleviates, ameliorates, relieves, inhibits, delays the onset of, reduces the severity of, and / or reduces the incidence of one or more symptoms, features, and / or causes of a particular disease, disorder, and / or condition. In some embodiments, such treatment may be directed to subjects who do not show signs of the relevant disease, disorder, and / or condition and / or to subjects who only show early signs of the disease, disorder, and / or condition. Alternatively or additionally, such treatment may be directed to subjects who show one or more established signs of the relevant disease, disorder, and / or condition. In some embodiments, treatment may be directed to subjects who have been diagnosed with the relevant disease, disorder, or condition. In some embodiments, treatment may be directed to subjects who are known to have one or more susceptibility factors that are statistically associated with an increased risk of the development of the relevant disease, disorder, and / or condition. DETAILED DESCRIPTION
[0170] Joint injuries often occur in physical activities, such as, but not limited to, repetitive and excessive exercise, overstretching and physical trauma. Treatment of joint injuries usually includes surgery. The tissues (including cartilage) inside the joint joint are usually difficult to reach by surgery, which brings challenges to the treatment of patients with damaged articular cartilage. Some current therapeutic intervention strategies usually involve removing damaged or detached cartilage from the joint. Such treatments usually provide temporary relief of injury symptoms, but they cannot treat the root cause of the damage or defect, and especially cannot prevent the gradual degeneration of cartilage.
[0171] The present disclosure provides improved techniques for treating tissue defects in joint joints. In particular, the present disclosure provides improved matrix-induced autologous chondrocyte implantation (MACI) techniques that can be used to repair tissue defects in joint joints in human subjects. For example, the present disclosure provides, in particular, techniques for arthroscopic delivery of MACI implants (also referred to as cell seeding support matrices). In some embodiments, the technology provided is characterized in that they achieve delivery characterized by cell numbers and viability comparable to those observed under non-arthroscopic delivery. The advantages of the method provided include, for example, that the invasiveness of arthroscopic delivery is much less than, for example, open surgical strategies that are commonly used to administer MACI implants. Therefore, the technology provided represents and embodies a further improvement relative to the MACI technology for treating cartilage defects.
[0172] Matrix-induced autologous chondrocyte implantation (MACI)
[0173] Matrix-induced autologous chondrocyte implantation (MACI) is a surgical procedure used to treat symptomatic full-thickness cartilage loss in joints. It also refers to a commercial product owned by Vericel Corporation, also known as autologous cultured chondrocytes on porcine collagen membranes. MACI is a registered trademark of Vericel Corporation, but is also used herein to describe a process and is therefore not always indicated with a registered symbol. MACI surgery is most commonly performed on the knee, but can also be performed on other joints. MACI improves the limitations of previous methods for treating cartilage defects using implanted chondrocytes, including the risk of uneven distribution of chondrocytes and hypertrophy of the graft during implantation. In view of the compliant nature of the scaffold or matrix on which chondrocytes are seeded before delivery to patients in need, the graft can be easily shaped to treat irregular cartilage defects and applied to joint surfaces with multi-planar geometries (e.g., pulleys) (Jones & Cash, 2019, Arthroscopy Techniques, 8 (3), 259-266).
[0174] As our understanding of cartilage biology and surgical techniques continues to advance, repair treatment options for symptomatic full-thickness cartilage and osteochondral destruction of the knee are also evolving. Since Brittberg et al. first proposed it in 1994, autologous chondrocyte implantation (ACI) has been widely used, and surgical utilization in the United States has almost doubled in the past decade. Although the long-term clinical results of the first generation of technology have demonstrated sustained functional improvement, there are still major technical challenges and adverse events associated with the necessary use of periosteal patches on defects. A large number of patients exhibit joint fibrosis and graft hypertrophy, which requires additional surgery to resolve these complications (Jones, KJ & Cash, BM, Arthrosc Tech, 2019). Ultimately, the use of periosteum was largely abandoned in 2007 in favor of the use of bioabsorbable collagen membrane covers, which significantly reduced graft hypertrophy and reoperation rates (Jones & Cash, 2019, Arthroscopy Techniques, 8 (3), 259-266).
[0175] Newer ACI techniques, including MACI, use cell-loaded membranes to avoid transplantation-related complications and simplify surgical techniques. The scaffolds (Vericel Corporation, Cambridge, MA) can use porcine type I / III collagen membranes seeded with densities ranging between 250,000 and 1 million cells / cm 2In a recent trial report on Superiority of MACI Implant Versus Microfracture Treatment, Treatment of cartilage defects (≥3cm 2 ) The 5-year clinical results after microfracture are clinically superior to those after microfracture treatment (Brittberg et al., 2018, Am. J. Sports Med., 46, 1343-1351). Additional case series reported similar mid-term and long-term results (Jones & Cash, 2019, Arthroscopy Techniques, 8 (3), 259-266).
[0176] cell
[0177] In some embodiments, the present disclosure utilizes cells from human or non-human (xenograft) sources. In some embodiments, the cells utilized are human cells.
[0178] In some embodiments, the cells utilized are autologous in that they are obtained from the same subject to which the matrix composition seeded with cells is administered as described herein. In some embodiments, the cells utilized are allogeneic in that they are isolated from tissue of a first subject, which is a different subject from the subject to which the matrix composition seeded with cells is administered.
[0179] In some embodiments, cells can be obtained from tissues collected from living sources (e.g., living humans). In some embodiments, cells can be obtained from tissues collected from adult organisms (e.g., adults). In some embodiments, cells can be obtained from tissues collected from humans under the age of 18. Alternatively or additionally, in some embodiments, cells can be obtained from tissues collected from dead sources (e.g., corpses). In some embodiments, cells can be obtained from tissues collected from living non-human organisms.
[0180] In some embodiments, the cells utilized include chondrocytes. In some embodiments, the cells utilized include human chondrocytes.
[0181] In some embodiments, cell preparations utilized in accordance with the present disclosure may be characterized, e.g., to confirm one or more features of cell identity and / or to exclude one or more contaminants or undesirable properties, etc. For example, in some embodiments, a preparation that is or contains chondrocytes may be evaluated for expression of one or more chondrocyte markers (e.g., to determine whether expression of such markers is above a predetermined threshold and / or is comparable to expression observed in an appropriate reference preparation) and / or one or more fibroblast markers (e.g., to determine whether expression of such markers is below a predetermined threshold and / or is comparable to expression observed in an appropriate reference preparation). In some embodiments, chondrocyte markers may be or include HAPLN1, MGP, EDIL3, WISP3, AGC1, COMP, COL2A1, COL9A1, COL11A1, LECT1, 81008, CRTAC1, SOX9, and NEBL.
[0182] Cells used in accordance with the presently disclosed techniques may be obtained from a biological sample, such as a tissue, cell culture, or other material, that may or may not contain chondrocytes.
[0183] In some embodiments, cell cultures can be grown from cells released from a cartilage biopsy. For example, chondrocytes can be cultured from a cartilage biopsy of a patient receiving an implant. An autologous chondrocyte product (Vericel Corporation, Cambridge, MA) is an example of a cultured chondrocyte product. In some embodiments, the cell culture includes a collagen matrix loaded with chondrocytes. Such chondrocytes can be obtained from a cartilage biopsy and cultured prior to loading onto the matrix, e.g., as in As used in implant products.
[0184] In some embodiments, autologous chondrocytes can be expanded in culture and then implanted into the subject from which the chondrocytes are isolated. In step 1, a cartilage biopsy from a patient receiving an autologous chondrocyte implant can be transported for processing (step 2). The biopsy material is digested at step 3 to release and collect chondrocytes from the cartilage. The released cells are plated in a tissue culture bottle and can be expanded in primary culture at step 4, and if necessary, subcultured. Once the cells reach a sufficient number, the cells can be optionally cryopreserved at step 5 until the patient is ready to receive the implant. Once the patient is ready to receive the cells, they can be thawed and plated in a tissue culture bottle and the cells can be grown to prepare for assembly culture (step 6). For the use of autologous chondrocyte implants, if a sufficient number of cells are obtained in the assembly culture, the cells can be centrifuged into a cell pellet and resuspended in the transport culture medium, which is the "final product", such as, for example The autologous chondrocyte product (step 8). This "final product" may undergo a number of quality control tests, including, for example, sterility testing, cell viability testing, endotoxin testing, mycoplasma testing, and / or culture component testing (step 9) to ensure that the cultured cells contain a sufficient number of chondrocytes. If the cultured cells pass all tests, the cells can be shipped (step 10) to the patient for implantation (step 11).
[0185] Alternatively, if you plan to use the assembled culture in step 6 When implanted, the cells can be resuspended in culture medium, seeded onto the collagen scaffold and cultured for 4 days (step 7). At the end of the culture period, the cells can be flushed with transport medium to produce The final product of the implant. This product may also undergo quality control testing. Therefore, whether the final product is cultured chondrocytes (such as autologous chondrocytes) suspension, or is the final product used for For scaffold seeding products of implants, assessment of cell identity can be used as a batch authentication assay or a batch release assay to confirm the composition of the cell culture as containing chondrocytes prior to shipping the culture.
[0186] In some embodiments, the RNA expression level of genes (e.g., HAPLN1) overexpressed by chondrocytes can be measured in cultured cells. In some embodiments, the RNA expression of genes (e.g., MFAP5) overexpressed by synoviocytes can be measured in cultured cells. In some embodiments, the RNA expression level can be presented as the ratio of the expression of chondrocyte markers (e.g., HAPLN1) to the expression of synoviocyte markers (MFAP5). In some embodiments, the cultured chondrocytes can show a relative RNA expression level (HAPLN1 vs. MFAP5) of about -2, about -1, about 0, about +1, about +2, about +3, about +4, about +5, about +6, about +7, about +8, about +9, about +10 or more on a logarithmic scale. In some embodiments, the cultured chondrocytes can show a relative RNA expression level ranging from about -2 to about +10, about -1 to about +9, about 1 to about 10, about +3 to about +8, about +5 to about +7 or a range thereof. In some embodiments, the cultured synoviocytes may exhibit a relative RNA expression level of about less than -2 on a logarithmic scale. In some embodiments, the cultured synoviocytes may exhibit a relative RNA expression level ranging from less than -2 to -10 on a logarithmic scale.
[0187] In some embodiments, chondrocytes prepared from a source cell preparation may be sufficient to seed a support matrix at least 250,000 cells / cm 2 The density of the chondrocytes is present in the culture. In some embodiments, the chondrocytes expanded in the culture may dedifferentiate when present in the monolayer culture. In some embodiments, the dedifferentiated chondrocytes may exhibit a fibroblast phenotype. In some embodiments, the dedifferentiated chondrocytes may downregulate the expression of genes (e.g., ACAN and / or COL2A1) encoding extracellular matrix (ECM) proteins. In some embodiments, the dedifferentiated chondrocytes may produce and / or secrete less amounts of ECM proteins, such as collagen (e.g., type II collagen) and / or aggrecan (also referred to as cartilage-specific proteoglycan core protein or chondroitin sulfate proteoglycan 1). Without wishing to be bound by theory, dedifferentiation may occur after the chondrocytes are removed from the three-dimensional cartilage matrix and observed during cell expansion in the monolayer culture.
[0188] In some embodiments, the chondrocyte preparations utilized herein contain a sufficient number of cells to seed a support matrix. In some embodiments, the chondrocyte preparations contain at least about 3×10 6 , 4×10 6 , 5×10 6 , 6×10 6 ,7×10 6 , 8×10 6,9×10 6 In some embodiments, the chondrocyte preparation comprises at least about 3×10 6 In some embodiments, the chondrocyte preparations disclosed herein contain at least about 1×10 7 , 2×10 7 , 3×10 7 , 4×10 7 , 5×10 7 , 6×10 7 ,7×10 7 , 8×10 7 ,9×10 7 In some embodiments, the chondrocyte preparations utilized herein contain at least 1×10 7 cells.
[0189] In some embodiments, the chondrocyte culture is about 50%, 60%, 70%, 80%, 90%, 95%, 98% or more confluent. In some embodiments, the chondrocyte culture is about 100% confluent. In some embodiments, the chondrocyte culture is about 50% to 90% confluent.
[0190] In some embodiments, the chondrocytes are present at a density of at least 250,000 cells / cm 2 , 300,000 cells / cm 2 , 400,000 cells / cm 2 , 500,000 cells / cm 2 , 600,000 cells / cm 2 , 700,000 cells / cm 2 , 800,000 cells / cm 2 , 900,000 cells / cm 2 , 1,000,000 cells / cm 2 or greater density on the support matrix.
[0191] The present disclosure particularly utilizes cell preparations in which a significant percentage of cells are viable; such highly viable cell preparations can greatly improve the successful treatment of a particular injury or defect, and may be necessary for the successful treatment of a particular injury or defect. In some embodiments, at least 70%, 75%, 80%, 85%, 90%, 95%, 98% or more of the cells present in the preparation are viable. In some embodiments, at least 90% of the chondrocytes in the preparation are viable.
[0192] In some embodiments, the compositions utilized herein of the present disclosure may be substantially free of components used during the preparation of the source cell preparation and during the expansion of the chondrocytes (e.g., fetal bovine serum albumin, fetal bovine serum, and / or horse serum). For example, in some embodiments, the compositions utilized herein include less than 10 μg / ml, 5 μg / ml, 4 μg / ml, 3 μg / ml, 2 μg / ml, 1 μg / ml, 0.05 μg / ml of fetal bovine serum albumin. In some embodiments, the cell preparation may be substantially free of mycoplasma, endotoxin, and / or microbial (e.g., aerobic microorganisms, anaerobic microorganisms, and / or fungi) contamination. In some embodiments, the cell preparation may be negative for mycoplasma, endotoxin, and / or microbial contamination tests.
[0193] Support matrix
[0194] The support matrix used according to the present disclosure can be made of relevant materials to which cells are attached. In some embodiments, the support matrix includes and / or is coated with an adhesive that facilitates and / or enables cell adhesion.
[0195] In some embodiments, the support matrix supports cell proliferation.
[0196] In some embodiments, the support matrix is bioabsorbable. In some such embodiments, the bioabsorbable matrix can be degraded in a period of hours, days, weeks or months. For example, the bioabsorbable matrix can be degraded in at least 24 hours, at least 7 days, at least 30 days or at least 6 months. In some embodiments, the support matrix can serve as a hemostatic barrier in a specific area that inhibits adjacent cells and tissues from penetrating into health, such as a need for treatment of a zone (e.g., joint joint).
[0197] In some embodiments, the support matrix can be a gel, a solid, or a semisolid. In some embodiments, the support matrix can be impermeable, permeable, or semipermeable (e.g., including holes). In some embodiments, the support matrix can be composed of synthetic materials, natural materials, or a combination thereof.
[0198] In some embodiments, the support matrix can have a structure that includes a membrane, microbeads, villi, threads, gel, or a combination thereof.
[0199] In some embodiments, the support matrix can be or include a biomaterial produced by cells; in some such embodiments, the biomaterial can be produced by cells in culture. Alternatively, in some such embodiments, the biomaterial can be produced by cells in a tissue (e.g., in vivo). In some embodiments, such biomaterials can be produced by cells that are allogeneic to the subject to be treated as described herein.
[0200] In some embodiments, the support matrix may be or include collagen. For example, the support matrix may be or include type I collagen, type II collagen, type III collagen, or a combination thereof (for example, a combination of type I collagen and type II collagen may be included, or a combination of type I collagen and type III collagen may be included). In some embodiments, the support matrix is mainly composed of type I collagen on the first side and type III collagen on the second side. In some embodiments, the first side of the support matrix including type I collagen is a smooth surface. In some embodiments, the second side of the support matrix including type III collagen is a rough surface. In some embodiments, the rough surface of the support matrix is suitable for cell inoculation. In some embodiments, the smooth surface of the support matrix is suitable for contacting the joint surface.
[0201] In some embodiments, some or all of the collagen in a support matrix used in accordance with the present disclosure may be cross-linked; in some embodiments, the collagen may be non-cross-linked.
[0202] In some embodiments, collagen utilized in accordance with the present disclosure can be derived from an animal such as a pig. In some embodiments, collagen can be derived from the peritoneum of a pig.
[0203] In some specific embodiments as described herein, the support matrix includes a combination of type I and type III porcine collagen.
[0204] In some embodiments, cells (e.g., chondrocytes) seeded onto and / or cultured on a support matrix as described herein can produce one or more extracellular matrix proteins (e.g., collagen) that interact with and / or are incorporated into the support matrix.
[0205] In some embodiments, the support matrix may include proteins, polypeptides, hyaluronic acid, and / or polymers (eg, elastin, fibrin, laminin, fibronectin). In some embodiments, the support matrix may be cell-free.
[0206] In some embodiments, the support matrix can have a surface area, size, shape and / or dimensions suitable for treating a specific cartilage or osteochondral defect, damage or injury. In some embodiments, the support matrix can be provided in a form (e.g., sheet form) that is easily shaped (e.g., by cutting, trimming, etc.) for application to a specific cartilage or osteochondral defect.
[0207] In some embodiments, the surface area of the support matrix can be up to about 10 cm 2 , 5cm 2 、4cm 2 , 3cm 2 , 2cm2 , 1cm 2 In some embodiments, the surface area of the support matrix may be about 2 cm 2 In some embodiments, the surface area of the support matrix can be about 3 cm 2 In some embodiments, the surface area of the support matrix can be about 4 cm 2 The size of the support matrix can be any size necessary to achieve the desired surface area suitable for treating cartilage and / or osteochondral defects. For example, 5 cm 2 The dimensions of the support matrix may be about 1 cm x 5 cm, 2 cm x 2.5 cm, 3 cm x 1.7 cm, or 4 cm x 1.3 cm. In some embodiments, the surface area of the support matrix (e.g., collagen membrane) may be about 5 cm 2 , which has a size of about 1 cm x 5 cm. In some embodiments, the surface area of the support matrix (e.g., collagen membrane) can be about 2 cm 2 , its size is about 2×1cm 2 In some embodiments, the maximum dimension of the support matrix does not exceed about 5 cm at its maximum length. In some embodiments, the maximum dimension of the support matrix does not exceed about 10 cm at its maximum length. In some embodiments, the support matrix has an irregular shape.
[0208] Cells seeded on support matrix
[0209] The present disclosure particularly utilizes compositions comprising cultured cells (eg, chondrocytes) seeded onto a supporting matrix (eg, a collagen membrane).
[0210] In some embodiments, the cell that is seeded on the support matrix can be adhered to. In some embodiments, the cell can adhere to the support matrix, and its adhesion degree is to make them not wash off from the matrix during the subsequent cell culture step, not shift from the matrix during transmission, and / or not shift from the matrix during the surgical operation of implanting the matrix.
[0211] In some embodiments, the present disclosure makes particular use of cell seeding support matrices in which a significant percentage of cells are viable; such highly viable cells present on the cell seeding matrix can greatly improve the successful treatment of a particular injury or defect, and may be necessary for the successful treatment of a particular injury or defect. In some embodiments, at least 70%, 75%, 80%, 85%, 90%, 95%, 98% or more of the cells present on the cell seeding matrix are viable. In some embodiments, at least 90% of the chondrocytes present on the cell seeding matrix are viable.
[0212] In some embodiments, the cells seeded on the cell seeding support matrix can live at least about 1 day, 2 days, 3 days, 4 days, 5 days, 6 days, 7 days, 8 days, 9 days, 10 days, 11 days, 12 days, 13 days, 2 weeks, 3 weeks or longer. In some embodiments, the cells seeded on the support matrix can split. In some embodiments, the cell seeding support matrix is stored at about 4°C to about 37°C.
[0213] In some embodiments, the cell-seeding support matrix comprises at least 250,000 cells / cm 2 , 300,000 cells / cm 2 , 400,000 cells / cm 2 , 500,000 cells / cm 2 , 600,000 cells / cm 2 , 700,000 cells / cm 2 , 800,000 cells / cm 2 , 900,000 cells / cm 2 , 1,000,000 cells / cm 2 In some embodiments, the cell population is greater than 250,000 cells / cm 2 , 300,000 cells / cm 2 , 400,000 cells / cm 2 , 500,000 cells / cm 2 , 600,000 cells / cm 2 , 700,000 cells / cm 2 , 800,000 cells / cm 2 , 900,000 cells / cm 2 , 1,000,000 cells / cm 2 The cell-seeded matrix is suitable for implantation into a subject.
[0214] In some embodiments, the cell seeding support matrix comprises at least 5×10 6 , 7.5×10 6 , 1.0×10 7 , 1.5×10 7 , 2.0×10 7 , 2.5×10 7 , 3.0×10 7 In some embodiments, 20 cm 2 Porcine type I and type III collagen membranes consisted of approximately 1.0 × 10 7 chondrocytes to about 2.0×10 7In some embodiments, 14.5 cm 2 Porcine type I and type III collagen membranes consisted of approximately 7.5 × 10 6 chondrocytes to about 1.5×10 7 A chondrocyte.
[0215] In some embodiments, the cell seeding support matrix may include a culture medium (e.g., DMEM) and supplements (e.g., fetal bovine serum, antibiotics). In some embodiments, the culture medium comprises about 7%, about 8%, about 9%, about 10%, about 11% fetal bovine serum. In some embodiments, the culture medium may be supplemented with 8.9%+ / -0.2% fetal bovine serum and gentamicin.
[0216] In some embodiments, the surface area of the cell seeding support matrix can be up to about 20 cm 2 , 10cm 2 , 5cm 2 , 4cm 2 , 3cm 2 , 2cm 2 , 1cm 2 In some embodiments, the surface area of the cell seeding support matrix can be about 2 cm 2 In some embodiments, the surface area of the cell seeding support matrix can be about 3 cm 2 In some embodiments, the surface area of the cell seeding support matrix can be about 4 cm 2 In some embodiments, the surface area of the cell seeding support matrix can be about 5 cm 2 In some embodiments, the maximum dimension of the cell seeding support matrix does not exceed about 5 cm at its maximum length. In some embodiments, the maximum dimension of the cell seeding support matrix does not exceed about 10 cm at its maximum length. In some embodiments, the cell seeding support matrix can be trimmed, shaped, cut, molded or formed and corresponds to the shape of the defect, damage and / or injury to be treated. In some embodiments, the cell seeding support matrix has an irregular shape.
[0217] In some embodiments, the cell seeding support matrix may be substantially free of components used during the preparation of the source cell preparation and during the expansion of the chondrocytes (e.g., fetal bovine serum albumin, fetal bovine serum and / or horse serum). For example, in some embodiments, the cell seeding support matrix utilized herein comprises less than 10 μg / ml, 5 μg / ml, 4 μg / ml, 3 μg / ml, 2 μg / ml, 1 μg / ml, 0.05 μg / ml of fetal bovine serum albumin. In some embodiments, the cell seeding support matrix may be substantially free of mycoplasma, endotoxin and / or microbial (e.g., aerobic microorganisms, anaerobic microorganisms and / or fungi) contamination.
[0218] In some embodiments, the cell seeding support matrix composition prepared and / or utilized according to the present disclosure includes a biocompatible adhesive or adhesive. In some embodiments, at least a portion of the cell seeding matrix can be coated with a biocompatible adhesive or adhesive. In some embodiments, the biocompatible adhesive or adhesive can form a layer above the cells on the support matrix. In some embodiments, the biocompatible adhesive or adhesive can form a layer below the cells on the support matrix. In some embodiments, the cell seeding support matrix includes multiple layers of biocompatible adhesive or adhesive and cells. In some embodiments, the biocompatible adhesive or adhesive can be impregnated in the support matrix.
[0219] In some embodiments, the present disclosure utilizes cells and adhesives and / or binders that are combined together on the surface or edge of a support matrix in a mixture of one or more alternating layers of cells and adhesives and / or binders.
[0220] In some embodiments, the biocompatible adhesive or glue used in the compositions of the present disclosure may include an organic fibrin glue (e.g., Fibrin glue (fibrin-based adhesive available from Baxter, Austria) or fibrin glue prepared using autologous blood during surgery.
[0221] Cell Sheet
[0222] The present disclosure particularly utilizes compositions comprising cultured cells (eg, chondrocytes) formed into a sheet (ie, a cell sheet).
[0223] In some embodiments, the cell sheet includes cells in their native extracellular matrix (ECM). In some embodiments, the cell sheet includes chondrocytes in their native ECM. In some embodiments, the native ECM includes collagen, proteoglycans, hyaluronic acid and / or chondroitin sulfate.
[0224] In some embodiments, the cell sheet comprises a confluent monolayer of cells, the confluent cells being in their native extracellular matrix.
[0225] Injury and location
[0226] In some embodiments, the disclosure contemplates the use of cells (e.g., chondrocytes) inoculated and grown on a support matrix (e.g., a collagen membrane) to treat / repair cartilage defects, damages, and / or injuries in a subject. In some embodiments, cartilage defects, damages, and / or injuries may be located at a joint joint (e.g., a knee, ankle, elbow, shoulder, hip, or wrist) of a subject. In some embodiments, the technology of the disclosure may be used to treat defects in the medial femoral condyle, lateral femoral condyle, patella, or pulley of a subject.
[0227] The types of injuries that may result in cartilage defects treatable using the disclosed technology may include, but are not limited to, injuries caused by chronic and / or repetitive motion, prolonged strenuous physical activity, and trauma. Some examples of chronic and / or repetitive motion include, but are not limited to, walking, running, bicycling, rock climbing, and other motions performed during exercise. Some examples of prolonged strenuous activity include, but are not limited to, lifting heavy objects and other forms of physical labor. Some examples of trauma include, but are not limited to, falls, collisions, and sports-related injuries.
[0228] In some embodiments, the subject to be treated is an adult. In some embodiments, the subject to be treated is under the age of 18. In some embodiments, the subject to be treated is a person between the ages of 10 and 17; in some such embodiments, the subject does not have an open growth plate. In some embodiments, the subject shows symptoms of cartilage defects. In some embodiments, symptoms of cartilage defects may include joint pain, joint swelling, and / or changes in joint flexibility and / or movement. In some embodiments, the subject may be asymptomatic.
[0229] method
[0230] The present disclosure provides techniques for delivering compositions, including cells, to a surgical site that can be used, for example, to treat cartilage and / or osteochondral lesions (eg, focal lesions in the load-bearing region of the knee cartilage).
[0231] In some embodiments, the present disclosure provides techniques that permit and / or enable treatment of clinically significant cartilage and / or osteochondral destruction, defects, injuries, and / or trauma. In some embodiments, treatment includes tissue repair and / or regeneration.
[0232] In some embodiments, an arthroscopic method can be used to implant a composition comprising chondrocytes into a subject at or near a site of destruction, defect, injury and / or trauma, such as at or near a joint surface. Joint surfaces that can be treated using the methods and compositions of the present disclosure include, for example, joint surfaces of the knee, ankle, wrist, hip, elbow, and / or shoulder.
[0233] Open Application
[0234] Traditionally, the operation at the position where the cell seeding support matrix is implanted into the defect, damage and / or injury is always carried out under the open surgical condition that the adjacent position needs a large incision. Traditionally, the implantation of the cell seeding support matrix is always carried out under aseptic conditions via the arthrotomy of the adjacent position. In many operations of these operations, minimally invasive arthrotomy is used. Minimally invasive arthrotomy for repairing knee defects (for example, the damage on condyle and patella) usually requires a length range of about 6cm to about 10cm. Open surgical procedures such as arthrotomy are usually used because they enable the surgeon to observe and measure the defect, and relatively easily physically manipulate the implant near the defect.
[0235] The present disclosure recognizes various disadvantages of open surgical approaches, including those traditionally used for MACI procedures, when compared to minimally invasive approaches such as arthroscopy. For example, relatively large incisions are required to perform many open surgical techniques, including those traditionally used for MACI procedures, which present an increased risk of infection, an increased risk of significant scarring, a longer recovery time, and increased pain severity relative to the same measurements after minimally invasive procedures such as arthroscopic implantation.
[0236] In such open surgery, an incision can usually be formed to allow access to the joint to be treated by surgery, so that the joint and its internal tissue (for example, cartilage) are exposed and visible to the doctor performing the operation. Generally, the preparation of the surgical site can include cleaning the site and removing the damaged cartilage from the site. Generally, the cell seeding support matrix is placed in a manner such that the cell faces (for example, contacts) the surface to be treated. In some such operations, the cell seeding support matrix is implanted in and / or above the site of damage, defect and / or injury. The cell seeding support matrix can be provided in the form (for example, sheet form) of easy shaping (for example, by folding, cutting, trimming, etc.), for application to cartilage or osteochondral defects. In some operations, the cell seeding support matrix is shaped into a form that is uniquely suitable for or adheres to the cartilage or osteochondral defects of a subject. Usually a fixing method is used to fasten the cell seeding support matrix in the site, such as fibrin glue fixation. The site can be closed then, so that the cell seeding matrix is left in the site.
[0237] Arthroscopic delivery
[0238] Arthroscopy (also known as arthroscopic surgery or keyhole surgery) is a minimally invasive surgical procedure performed on a joint in which an arthroscope (which is an endoscope inserted into the joint through a small incision) is used to examine and / or treat the damage. Arthroscopic surgery can be performed in a variety of surgical settings, including but not limited to ACL reconstruction, meniscus reconstruction, and cartilage repair.
[0239] Arthroscopic surgery has become the preferred surgical method, at least in part because it has a positive impact on patient health outcomes, including but not limited to minimal soft tissue trauma, minimal postoperative pain, rapid healing time, and low infection rates. Many surgical repairs that benefit from MACI are performed at sites accessible using arthroscopic surgical methods. The present disclosure provides techniques that permit MACI surgery via arthroscopic delivery methods.
[0240] An important advantage of arthroscopic surgery over traditional open surgery is that the joint does not need to be opened and fully exposed during surgery. In some arthroscopic surgeries performed on the knee, only about two small incisions are made: one for the arthroscope and at least one for the surgical instruments to be used in the knee cavity. Compared with traditional open surgery, this can reduce recovery time and increase success rates due to reduced trauma to connective tissue. In recent years, arthroscopy has become increasingly popular, at least in part because there is evidence that recovery time is faster and scarring is less, which is at least in part due to smaller incisions. An irrigating fluid (most commonly saline) can be used to expand the joint and create a surgical space.
[0241] In a typical arthroscopic procedure, the surgical instruments used are smaller than traditional surgical instruments. The surgeon views the joint area on a video monitor and can diagnose and repair defects in the joint tissue. It is possible to perform an arthroscopic examination of almost every joint. Arthroscopic surgery is most often performed on the knee, shoulder, elbow, wrist, ankle, foot, and hip.
[0242] The present disclosure recognizes the source of the challenges encountered when delivering cell seeding matrix components via arthroscopic surgery. For example, the present disclosure particularly determines that if the technology described herein is lacking, it may be difficult or impossible to maintain appropriate (e.g., sufficient) cell viability levels. The present disclosure particularly provides a solution. For example, the present disclosure provides a technology that is proven to achieve arthroscopic delivery herein, while maintaining acceptable cell viability (e.g., as assessed by one or more parameters described herein) compared to the cell viability found under certain open surgical methods. The present disclosure describes some surprising and unexpected results (e.g., referring to Example 5 herein) that can be achieved by the technology provided, including that the cell viability level can exceed the cell viability level obtained by certain open surgical delivery methods.
[0243] In some embodiments, at least two incisions may be formed adjacent to the location of the defect to be treated arthroscopically. In some embodiments, the length of the incisions may range from about 1 cm to about 3 cm. In some embodiments, at least one incision may be formed to accommodate insertion of an arthroscope. In some embodiments, at least one incision may be formed to accommodate insertion of a cannula. In some embodiments, at least 2, at least 3, or at least 4 incisions may be formed. In some embodiments, at least 2 incisions may be formed, each of which accommodates insertion of a cannula.
[0244] In some embodiments, the size and / or shape of the defect can be determined prior to arthroscopic implantation of the cell-seeded matrix into the defect. In some embodiments, the size and / or shape of the defect can be determined by using a surgical measuring device. In the present disclosure, the surgical measuring device can be an arthroscopic probe and a ruler with millimeter-level spacing markings.
[0245] In some embodiments, a matrix cutter can be used to cut the cell seeding support matrix to form regular shapes (eg, oval, circular, rectangular, square, etc.).
[0246] In some embodiments, arthroscopic technique can be used to implant cell seeding support matrix into the position of defect, damage and / or injury. In some embodiments, when arthroscopic technique is used to implant cell seeding support matrix into the position of defect, damage and / or injury, the matrix can be placed in a manner that the cell faces (for example, contacts) the surface to be treated. In some embodiments, the cell seeding support matrix can be implanted into the position of damage, defect and / or injury by arthroscopic technique and / or above. In some embodiments, the cell seeding support matrix can be provided in the form (for example, sheet form) of easily forming (for example, by cutting, pruning, etc.), for arthroscopic application to cartilage or osteochondral defect. In some embodiments, before arthroscopic implantation, the cell seeding support matrix can be cut or shaped into the form of cartilage or osteochondral defect that is uniquely suitable for or adheres to the subject.
[0247] In some embodiments, a cartilage area surrounding the defect or destruction is defined by pressing a sharp cutting tool (e.g., an articulating arthroscopic cutting tool) into the cartilage, and then the cartilage area is removed using one or more cutting tools (e.g., a circular curette, a square curette, or a rake curette) to form an exposed bone area of a specific shape (e.g., oval, elliptical, circular, square, rectangular, etc.).
[0248] In some embodiments, a single matrix may be utilized to treat multiple defects arthroscopically. In some embodiments, multiple defects may be treated, each defect being treated with a different matrix, at least some of which are delivered arthroscopically. In some embodiments, one or more defects may be treated arthroscopically with multiple separate matrices.
[0249] In some embodiments, following treatment comprising arthroscopic delivery of a composition of the present disclosure, a screening method (e.g., magnetic resonance imaging) may be used to assess the treated area (e.g., a joint). In some embodiments, the treated area may be assessed for filling, repair, and / or healing of a defect, disfigurement, and / or injury.
[0250] In some embodiments, the cell seeding support matrix can be implanted arthroscopically at the site of the defect, damage and / or injury using at least one tool selected from a cannula assembly, an articulating arthroscopic cutting tool, a circular curette, a square curette, a rake curette, a matrix shuttle delivery device, and a smear tool.
[0251] In some embodiments, the inner diameter of the sleeve may be about at least 5mm, at least 6mm, at least 7mm, at least 8mm, at least 9mm or at least 10mm. In some embodiments, the inner diameter of the sleeve may be about 8mm to about 9mm. In some embodiments, the inner diameter of the sleeve may be greater than 10mm. In some embodiments, the inner diameter of the sleeve may be about 15mm to about 20mm. In some embodiments, the length of the sleeve may be about 2cm, about 3cm, about 4cm, about 5cm, about 6cm, about 7cm, about 8cm, about 9cm or about 10cm or longer. In some embodiments, the length of the sleeve may be in the range of about 2cm to about 10cm. In some embodiments, the length of the sleeve is about 4.5cm. In some embodiments, the length of the sleeve may depend on the location of the defect to be treated. For example, the length of the sleeve for treating a hip defect may be about 12cm to about 20cm. In some embodiments, the length of the sleeve for treating a hip defect may be about 16.5cm. In some embodiments, the length of the sleeve for treating a shoulder defect may be about 12 cm to about 20 cm. In some embodiments, the length of the sleeve for treating a shoulder defect may be about 16.5 cm. As an additional example, the length of the sleeve for treating a knee defect may be in the range of about 2 cm to about 7 cm. In some embodiments, the length of the sleeve for treating a knee defect may be about 4.5 cm. In some embodiments, the sleeve may be made of a material including plastic. In some embodiments, the sleeve may be made of a material including metal. In some embodiments, the sleeve may be made of a material selected from the group consisting of: plastic, metal, rubber, silicone, fiberglass, and combinations thereof (e.g., composite materials).
[0252] In some embodiments, one end of the sleeve can be truncated into a curved shape around the circumference of the sleeve and can form a curved assessment edge that can aid in visual inspection of a curved condyle or other surface on a bone.
[0253] In some embodiments, the cell seeding support matrix can be delivered to the surgical site arthroscopically by using forceps or other tools to place previously cut or formed portions of the cell seeding support matrix onto a matrix shuttle device, pushing the shuttle device into a cannula positioned in the surgical site, depressing a plunger on the matrix shuttle device to push out deployment wings that can deliver the cell seeding support matrix to the surgical site. In some embodiments, the cell seeding support matrix can traverse the entire length of the cannula.
[0254] In some embodiments, after the cell seeding support matrix is implanted into defect, damage and / or injury, for example, biocompatible adhesive, sealant or suture can be used to fasten the cover patch. In some embodiments, the cover patch can be used to cover a certain district to prevent undesirable cells and / or biological factors (for example, fibroblasts, macrophages) from infiltrating into the district to be treated from surrounding tissue. In some embodiments, the cover patch includes any support matrix described herein, and / or can include hyaluronic acid, fibrin and / or polylactic acid. In some embodiments, the cover patch can be cell-free and absorbable. In some embodiments, the cover patch can be semi-permeable.
[0255] In some embodiments, the biocompatible adhesive or glue used to secure the cover patch may include an organic fibrin glue or sealant (e.g., Fibrin glue (fibrin-based adhesive available from Baxter, Austria) or fibrin glue prepared using autologous blood during surgery.
[0256] In some embodiments, a biocompatible adhesive or adhesive may be applied to the defect before the cell seeding support matrix is placed over or into the defect. In some embodiments, a biocompatible adhesive or adhesive may be applied to the cell seeding support matrix and then placed over or into the defect. In some embodiments, a biocompatible adhesive or adhesive may be applied to the periphery of the implanted cell seeding support matrix.
[0257] Figure 1A schematic diagram of a method 10 for performing arthroscopic surgery according to aspects of an embodiment of the present invention is shown. The method 10 may generally include the following steps: forming an incision in a patient at an injured joint (e.g., knee, shoulder, elbow, etc.) (step 12); installing a cannula in the incision (step 14); using an arthroscopic measuring probe to measure the defect in the cartilage at the joint (step 16); using an articulated arthroscopic cutting tool to outline and score the cartilage surrounding the defect in a specific shape (e.g., oval, circular, square, rectangular, oblong, etc.) (step 18); using a cutting tool (e.g., a rake curette, a ring curette, a square curette, etc.) to cut, remove and clear the cartilage within the outlined shape (step 20) ; drying the surgical site where cartilage is removed by stopping the flow of fluid, draining, aspirating and drying using an applicator (step 22); applying fibrin glue to the surgical site (step 23); using a matrix cutter to cut a portion of the cell-seeded support matrix (or MACI graft or MACI implant) (step 24); using a matrix shuttle delivery device to deliver and implant the cell-seeded support matrix into the prepared surgical site (step 26); and using a applicator to apply fibrin glue (or other suitable material) to the defect site (step 28).
[0258] Figure 2 Views of an exemplary arthroscopic surgical procedure are shown in accordance with aspects of embodiments of the present invention. Figure 2 A corresponds to step 16 of method 10, and illustrates a cartilage covered joint 42. In some embodiments, this joint may be the medial femoral condyle, the lateral femoral condyle, the patella, or the trochlea, or other joint of the subject or patient. Figure 2 A also shows a flexible ruler 44 extending from the measuring tool. Figure 2 B corresponds to step 18 of method 10 and shows a sharp blade 46 attached to an articulated arm 48 for cutting cartilage 42 . Figure 2 C corresponds to step 20 of method 10 and shows a ring-shaped curette 50 removing a portion of cartilage 42 . Figure 2 D corresponds to step 22 of method 10 and shows matrix applicator 56 drying exposed bone 54 at a joint where contour 52 is defined by resection of cartilage 42 . Figure 2 E corresponds to step 26 of method 10 and shows a shuttle device 58 delivering a portion of a pre-cut cell seeding support matrix 60 matching the shape of the prepared region 52 into the cartilage 42 . Figure 2 F corresponds to step 28 of method 10 and shows a spreading tool 62 within the cut region 52 of the cartilage 42, adjusting the position of the cell seeding support matrix 60 and spreading fibrin glue.
[0259] System / Tool / Device
[0260] Provided herein are systems, tools, devices, and instrument systems that can be used to practice the methods of the present invention, which will allow the methods of the present invention to be conveniently practiced in a surgical setting.
[0261] In some embodiments, at least one custom device or tool may be used to perform the methods described herein.
[0262] Figure 3 A schematic diagram of a method 70 for using a cannula assembly during an arthroscopic surgical procedure according to aspects of an embodiment of the present invention is shown. The method 70 may generally include the following steps: inserting the cannula assembly into an incision at a patient's joint (step 72), wherein the cannula assembly may include an obturator and a barrier seal subassembly. Once the cannula assembly is inserted, the method 70 may include pushing and twisting the cannula body clockwise to secure it at the incision site (step 74); retracting the obturator and removing it from the cannula assembly (step 76), leaving the cannula body and the barrier seal subassembly to perform one or more arthroscopic surgical procedures (step 78). If desired, the barrier seal subassembly may be removed from the cannula body by pressing tabs on each side of the barrier body to release the barrier body (step 80). When the arthroscopic surgical procedure is completed, the cannula body may be removed from the incision site by twisting it counterclockwise (step 82).
[0263] Figure 4 1 shows a perspective view of a cannula assembly 90 according to aspects of an embodiment of the present invention. Generally speaking, the cannula assembly 90 may include an obturator 92, a barrier seal subassembly 94, and a cannula body 96. The barrier seal subassembly may be released via a barrier release clip 114 (in Figure 5 1 and 2. The barrier release clip 120 may be releasably attached to a projection 128 on the cannula body 96 such that the barrier seal subassembly 94 and the cannula body 96 are coupled together. The obturator 92 may be coaxially inserted through both the cannula body 96 and the barrier seal subassembly 94. Generally speaking, in some embodiments, the obturator may be used as a handle for pushing and twisting the cannula assembly into the incision site. A plurality of slats 102 on the proximal handle portion 100 of the obturator may aid in manually gripping and manipulating the obturator during insertion of the cannula assembly and may improve certain aspects of manufacturing the obturator.
[0264] Figure 5The manner in which the obturator 92 and the barrier seal subassembly 94 fit together according to aspects of embodiments of the present invention is shown. Generally speaking, the obturator may have two or more protruding rotational tabs 110 on the bottom surface of the proximal handle portion 100, which fit into two or more corresponding recesses 112 in the top portion of the barrier seal subassembly 94. During insertion of the cannula assembly, the rotational tabs 110 and the recesses 112 may assist in the combined movement of the cannula assembly to enhance the rotational movement of the cannula assembly while not restricting the axial movement of the obturator 92 relative to the barrier subassembly 94. Generally speaking, the obturator includes: a proximal handle portion 100, which is shaped like a dome to accommodate the operator's hand; a distal conical tip 106, which helps push the cannula assembly into the surgical incision; and a shaft portion 104, which connects the handle portion 100 with the tip portion 106. In some embodiments, a plurality of slats 102 on the proximal handle portion 100 of the obturator can aid in manually grasping and manipulating the obturator during insertion of the cannula assembly and can improve certain aspects of manufacturing the obturator. One or more concave portions 180 can be present on the handle portion 100 and can enhance manual grasping and manipulating the obturator during certain methods. Certain aspects of the obturator 92 are also shown in Fig.13 and described below.
[0265] Figure 6 and Figure 8 Two different perspectives are shown, and Figure 7 A side view of a cannula body 96 according to various aspects of an embodiment of the present invention is shown. The cannula body 96 may generally include a hollow cylinder 120 that is wrapped in a helical thread 126 along the entire length of the hollow cylinder 120. In some embodiments of the present disclosure and the present arthroscopic surgical method, the threads around the cannula body can assist in gripping the incision site and allow the surgeon to expand the internal volume at the surgical site. The cannula body 120 may also include a circular lip portion 122 near the proximal end of the hollow cylinder 120, with two protrusions 128 positioned on the circular lip portion opposite to each other. In some embodiments of the present disclosure, these protrusions can releasably engage with two corresponding barrier release clips 114 on the barrier seal subassembly so that the barrier seal subassembly can be removed from or attached to the cannula body.
[0266] Still reference Figure 6 and Figure 7, the distal end of the hollow cylinder 120 may terminate in a circumference 130 that is curved relative to a plane perpendicular to the central axis of the hollow cylinder 120. This curved circumference 130 may be further outlined with dark lines so that it can serve as a visual guide for assessing the curvature of the surgical site. Depending on the diameter of the hollow cylinder 120, the magnitude of the curvature of the curved circumference may vary. In addition, at least two additional visual markers 132 along the dark lines of the circumference may be applied at relative locations and may assist as visual landmarks. In some embodiments, the visual marker 132 may extend proximally from the curved circumference 130 at the distal end of the hollow cylinder 120 by about 0.1 mm to about 10 mm, or about 0.1 mm to about 0.5 mm, or about 0.1 mm to about 1.0 mm, or about 0.1 mm to about 0.8 mm, or about 0.1 mm to about 0.5 mm, or about 0.2 mm to about 1.0 mm, or about 0.2 mm to about 0.8 mm and / or about 0.2 mm to about 0.5 mm.
[0267] In some embodiments, the cannula body 96 can include a translucent polycarbonate material. The translucent material can improve optical viewing of the surgical site during a surgical procedure through the cannula body 96. In some embodiments, the cannula body 96 can include or be constructed of a plastic, a polymer, a metal, or a composite or hybrid material.
[0268] Fig. 9 1 shows a perspective view of a barrier seal subassembly according to aspects of an embodiment of the present invention. In general, the barrier seal subassembly may include one or more barrier seals 154, 156, 158 (in the embodiment of the present invention) enclosed within one or more outer members 148, 150. Figures 10 to 12 ), and can be used to form a flexible interface through which various arthroscopic surgical tools can enter the sleeve and interact at the surgical site, and the flexible interface can be used to retain liquids, fluids, tissues or other materials. The outer members 148, 150 may include a baffle top member 148 and a baffle bottom member 150, which are Fig.10 148 and described below. The baffle top member 148 may include a flat top surface 146 and a circular hole 144, and notches 112 disposed at relative positions (e.g., approximately 180 degrees apart) on the circumference of the circular hole 144. The notches 112 may be coupled to the rotational protrusions 110 on the obturator 92 (described above in Figure 5 ).
[0269] Fig.101 shows a perspective exploded view of the components of the barrier seal subassembly 94 according to aspects of an embodiment of the present invention. The barrier seal subassembly 94 may generally include a barrier top component 148, at least one barrier seal 158, 154, 156, and a barrier bottom component 150. In some embodiments, Fig.10 All components shown fit together coaxially, or are longitudinally or axially aligned, and are stacked parallel to one another. Generally speaking, barrier top member 148 and barrier bottom member 150 can enclose barrier seals 158, 154, 156 to form a flexible barrier seal assembly that can enable various arthroscopic surgical tools to be inserted into the cannula to perform a surgical procedure while maintaining fluids (e.g., sterile saline solution, sterile fluids, and other materials) within the surgical site.
[0270] In some embodiments, baffle top member 148 and baffle bottom member 150 may include acrylonitrile butadiene styrene (ABS) or other similar polymer or plastic material.
[0271] Still reference Fig.10 , the top barrier seal 148 includes a flat circular portion 151 having a circular hole in the center 154. The top barrier seal 148 may also include a plurality of legs 152 protruding vertically downward from the bottom surface of the top barrier seal 148. The legs 152 include tapered cylindrical rods. In some embodiments, the legs 152 are evenly distributed around the circumference of the top barrier seal 148 (e.g., 6 legs spaced approximately 60 degrees apart, or 4 legs spaced approximately 90 degrees apart). The top barrier seal may also include two or more notches 112 positioned at the edge of the circular center hole 154 in relative positions (e.g., spaced 180 degrees apart) and may be coupled to corresponding rotational protrusions 110 in the obturator 92.
[0272] According to various aspects of the embodiments of the present invention, Fig.11 A perspective view of barrier seals 156, 158 having slits is shown, and Fig.12 A perspective view of a barrier seal 154 with a hole is shown. Generally, one or more barrier seals are coaxially stacked together to form a flexible barrier seal. In some embodiments, the barrier seal comprises silicone or ethylene propylene diene monomer rubber (EPDM rubber), or other flexible polymer materials. The barrier seals 156, 158 with slits and the barrier seal 154 with holes may also include a plurality of small circular holes 170, 174 disposed about the circumference of the disk corresponding to the legs 152 of the top barrier seal 148. In some embodiments, when the barrier seals are coaxially stacked, the legs 152 may pass through the holes 170, 174.
[0273] refer to Fig.11, Fig.11 The illustrated barrier seal 156, 158 with slits may comprise a circular disk and may feature three or more slits cut in the disk extending from the center toward the outer edge and at equal angles to one another. In some embodiments, there may be three slits 172 spaced approximately 120 degrees apart. Fig.12 , Fig.12 The illustrated barrier seal 154 having an aperture may include a circular disk and may feature a small circular hole in the center of the disk.
[0274] Still reference Figures 9 to 12 , each of the barrier seals 154, 156, 158 may include one or more slits 172 or zero to one center hole 176 disposed therethrough to allow the occluder 92 to be pushed through the center of each of the barrier seals 154, 156, 158. As the occluder 92 is pushed through, the slits 172 bend downwardly (i.e., distally). When the occluder is removed from the barrier assembly 94, each of the slits 172 moves back to its original position (i.e., coplanar with the remainder of the corresponding barrier seal 154, 156, 158). Fig.10 In the illustrated embodiment, two of the three barrier seals 156, 158 each include three slits 172 oriented approximately 120 degrees apart from one another, wherein the slits 172 of one of the barrier seals 156 are rotated approximately 60 degrees relative to the slits 172 of the other barrier seal 158 to minimize leakage in the barrier assembly when retrieving the obturator 92. The third barrier seal 154 may include an aperture 176 disposed therethrough to help keep the obturator 92 centered within the barrier assembly 94. Each of the barrier seals 154, 156, 158 may be constructed of a polymer material having sufficient flexibility and resiliency and also including a degree of shape memory.
[0275] According to various aspects of the embodiments of the present invention, Fig.13 shows a perspective view of the obturator, and Fig.14A side view of the obturator is shown. Generally speaking, the obturator includes a proximal handle portion 100 that is shaped like a dome to accommodate the operator's hand; a distal conical tip 106 that facilitates pushing the cannula assembly into the surgical incision; and a shaft portion 104 that connects the handle portion 100 with the tip portion 106. In some embodiments, a plurality of slats 102 on the proximal handle portion 100 of the obturator can facilitate manual gripping and manipulation of the obturator during insertion of the cannula assembly and can improve certain aspects of manufacturing the obturator. For example, each of the slats 102 and the vertical members that bridge the gaps between the slats 102 can have a consistent thickness so that they can be produced via a molding process (i.e., an injection molding process using coring), wherein the heating and cooling processes during manufacturing result in the entire obturator 92 having consistent thermal and / or heat treatment properties (thereby reducing material property variations in the final part).
[0276] Fig.15 A view of an obturator 100 and barrier seal subassembly 94 positioned near a cannula body 96 inserted into an incision 190 at a joint is shown in accordance with aspects of an embodiment of the present invention. The obturator 100 is inserted through the barrier seal subassembly 94 so that they can be manipulated together as a combined object. The conical distal end 106 of the obturator points toward the opening of the cannula body 96. The barrier release clip 164 can be used to releasably engage with a corresponding projection on the cannula body 96. The cannula body 96 is inserted into the cannula body 96. Fig.15 is shown as being made of a clear polymer material to help improve visibility within the surgical site.
[0277] In some embodiments, an adjustable arthroscopic measurement device or arthroscopic measurement probe is used to assess the size and shape of at least one lesion or defect in cartilage at a surgical site.
[0278] Fig.16 A schematic diagram of a method 200 using an arthroscopic measurement probe 210 is shown in accordance with aspects of an embodiment of the present invention. The method 200 may generally include inserting the measurement probe 210 into the barrier seal subassembly 94 and the cannula body 96 (step 202). A flexible ruler 218 may be extended from the measurement probe in the vicinity of the defect or imperfection (step 204). The size and shape of the defect or imperfection may be measured by visual comparison to regular markings on the ruler 218 (step 206). The adjustable nature of the measurement probe 210 may allow the ruler 218 to be rotated and extended or retracted to better align the ruler 218 with various features of the defect or imperfection. Once the measurement is complete, the ruler 218 may be retracted into the measurement probe 210, removed from the surgical site, and retracted outwardly from the barrier seal subassembly and the cannula body (step 208).
[0279] Fig.17 and Fig.18 A perspective view of an arthroscopic measurement probe assembly 210 according to aspects of an embodiment of the present invention is shown. In general, the measurement probe 210 may include a handle 212, an adjustment knob 214, a rotation plug 222, a positioning pin 224, a travel arm 226, a sizing tube 216, and a flexible ruler 218. In some embodiments, the rotation plug 222, the adjustment knob 214, the travel arm 226, the sizing tube 216, and the flexible ruler 218 are all coaxially connected, so that the adjustment knob 214 can be used to extend the ruler 218 and rotate the sizing tube 216, and the flexible ruler 218 can be disposed through the interior of the sizing tube 216. In some embodiments, the distal end 220 of the sizing tube 216 can be bent so that there can be a bend at an angle of 90 degrees, or 85 to 95 degrees, or 75 to 105 degrees. In some embodiments, the radius of curvature of the bend at the distal end 220 of the sizing tube 216 may have a radius of curvature of approximately 0.11 inches, or approximately 0.05 inches to 0.2 inches.
[0280] Fig.18 A perspective exploded view of a portion of an arthroscopic measurement probe assembly according to various aspects of an embodiment of the present invention is shown. In general, the handle 212 may include two pieces: a top shell piece 211 and a bottom shell piece 213. The adjustment knob 214 may be connected to the travel arm 226 by a locating pin 224, which may pass through a slit 236 disposed in the calibrating tube 216. The locating pin 222 may also be connected at the proximal end of the travel arm 226 and the adjustment knob 214. In some embodiments, the arrangement and connection of these components may enable the adjustment knob 214 to be pushed along the longitudinal axis of the measurement probe device 210 to extend and retract the flexible ruler 218, and to enable the adjustment knob 214 to be rotated to rotate the calibrating tube 216. The overall effect of these combined movements is that the flexible ruler 218 can be deployed in a variety of angles and positions within the surgical site to facilitate measurement of damage or defects.
[0281] In some embodiments, the top shell member 211 and the bottom shell member 213 of the handle 212 include acrylonitrile butadiene styrene (ABS) or other similar plastic or polymer materials and can be held together via crush pins (e.g., matching offset features such as a cylindrical protrusion in the top shell member 211 that abuts against a corresponding octagonal sleeve in the bottom shell member 213, or vice versa), thereby holding the two members 211, 213 together via friction.
[0282] Fig.19A flexible ruler 218 for arthroscopic measurement probe 210 according to various aspects of an embodiment of the present invention is shown. In general, the flexible ruler 218 includes a cylindrical rod 230, which includes a flexible material that can bend and maintain shape. In some embodiments, the cylindrical rod 230 may include one of the following items or be composed of one of the following items: polyetheretherketone (PEEK) or a metal wire or a polymer material or a combination of a polymer and a metal material. One or more materials constituting the cylindrical rod 230 can enable the flexible ruler 218 to bend through the curved opening 220 of the calibrating tube 216, and maintain a substantially straight portion when extended for easy measurement. The flexible ruler 218 may also have a plurality of markings 232, which are distributed near the distal end of the rod along a certain length of the outer surface of the cylindrical rod 230. The markings 232 include thin lines perpendicular to the longitudinal axis of the cylindrical rod 230 and can be spaced at intervals of 2.5mm and 5.0mm. In some embodiments, the markings 232 may be imprinted on the scale 218 by one or more methods including laser etching, physical etching, screen printing, and / or ink marking.
[0283] Fig. 20 A calibrator 216 for an arthroscopic measurement probe 210 according to various aspects of an embodiment of the present invention is shown. In general, the calibrator 216 includes a hollow cylindrical tube 234 having two slits 236 disposed at opposite positions at its proximal end. The calibrator 216 may also include a bend 238 at the distal end of the tube so that the opening of the tube 240 points away from the longitudinal axis of the tube at an angle (to allow measurement of a surface that is substantially orthogonal to the axial or longitudinal direction). In some embodiments, this angle may be about 90 degrees. In some embodiments, this angle may be about 75 degrees to about 105 degrees. In some embodiments, the radius of curvature of the bend 238 may be about 0.11 inches. In some embodiments, the radius of curvature of the bend 238 may be about 0.05 inches to about 0.25 inches. In some embodiments, the calibrator 216 may include at least one of stainless steel T304, stainless steel T316, or a fractional hypodermic injection tube.
[0284] Fig.21A perspective view of an arthroscopic measuring probe 210 assembly according to various aspects of an embodiment of the present invention is shown, wherein arrows indicate movement and an extended ruler 218 is shown. The handle 212, adjustment knob 214, calibrator 216, and flexible ruler 218 are shown, and they are the same as described above. The adjustment knob 214 is shown here in its most extended position, closer to the distal end of the handle. Correspondingly, the ruler 218 is shown to be completely extended from the calibrator. The straight double-headed arrow indicates the ability of the ruler 218 to extend and retract. The curved arrow indicates that the calibrator 216 can be rotated along its longitudinal axis so that the extended ruler 218 can point to different directions.
[0285] In the present disclosure, a variety of cutting tools are described. Each tool may have one or more surgically sharp cutting edges that may be processed or manufactured to have a sufficiently sharp break edge to easily perform sharp cutting in biological materials that may include skin, cartilage, and / or bone. For example, in some embodiments, the cutting edge may include a break edge of 0.002 inches, 0.001 inches, or less than 0.001 inches, and various sub-ranges therebetween.
[0286] Fig. 22 A schematic diagram of a method 250 of using an articulating arthroscopic cutting tool 270 during an arthroscopic surgical procedure is shown in accordance with aspects of embodiments of the present invention. In general, method 250 includes: selecting the size of an articulating arthroscopic cutting tool 270 based on the measurements obtained using the above-mentioned method 200 for measuring the size of a defect or damage in cartilage (step 252); removing the barrier seal subassembly from the sleeve, stopping the flow of fluid, and drying the defect site (step 253); inserting the articulating arthroscopic cutting tool 270 into the sleeve 96 and barrier seal subassembly 94 at the surgical site (step 254); using the thumb slider 274 on the handle 286 of the articulating arthroscopic cutting tool 270 to tilt the blade 278 on the cutting tool to the appropriate angle and lock the angle in the appropriate position; pressing the blade 278 into the cartilage 42 at the surgical site surrounding the defect or damage (step 258); and removing the articulating arthroscopic cutting tool 270 from the sleeve 96 and barrier seal subassembly 94 (step 260). Once inserted into the cannula, the articulating arthroscopic cutting tool 270 may be rotated within the cannula 96 from zero to 360 degrees (and subranges therebetween) (e.g., with the shaft 276 concentrically disposed within the cannula). In some embodiments, after the method 250 is completed, at least one oval profile 52 (in the shape of the blade 278) defined in the cartilage may remain. Figure 2 D). Further methods that may be performed after method 250 are described by method 330 and by Fig.30 Shown.
[0287] Fig.23 A perspective view of an articulating arthroscopic cutting tool assembly 270 is shown in accordance with aspects of an embodiment of the present invention. In general, the articulating arthroscopic cutting tool assembly 270 includes: a handle 272; a thumb slider 274; a linear stator shaft 276; a curved oval blade 278 connected to the linear stator shaft 276 by an articulating joint 280; a linear drive shaft 292 connected to the thumb slider 274; and a linkage 282 connected to both the linear drive shaft 292 and the curved oval blade 278. In some embodiments, the linkage 282 is connected to the curved oval blade 278 at the joint 284. In some embodiments, movement of the thumb slider 274 along the longitudinal axis of the handle causes the curved oval blade 278 to tilt about the joint 280 relative to the linear stator shaft and relative to the longitudinal axis of the articulating arthroscopic cutting tool 270. In some embodiments, the curvature of the oval blade 278 can allow it to follow a curved surface of a joint of a subject or patient, such as the medial femoral condyle, lateral femoral condyle, patella, or trochlea.
[0288] Fig.24 A perspective view of the distal end of an articulating arthroscopic cutting tool assembly 270 is shown in accordance with aspects of an embodiment of the present invention. Generally speaking, because linkage 282 is connected to both linear drive shaft 292 and curved oval blade 278, movement of thumb slide 274 causes curved oval blade 278 to tilt about an axis at joint 280 such that the angle of curved oval blade 278 relative to the longitudinal axis of articulating arthroscopic cutting tool assembly 270 changes.
[0289] Fig.25 A perspective exploded view of a portion of an articulated arthroscopic cutting tool assembly 270 according to various aspects of an embodiment of the present invention is shown. In general, the handle includes an upper shell 286 and a lower shell 288 that converge to form the handle. In some embodiments, the upper shell 286 includes a ridged semi-cylinder having a rectangular opening 290 extending longitudinally along the ridged semi-cylinder, and the lower shell 288 includes a ridged semi-cylinder. In some embodiments, when the two shells 286, 288 are closed together to form a complete cylinder, a small circular opening 298 may be present at the distal end of the handle. In some embodiments, the ridges on the upper shell 286 and the lower shell 288 on the handle extend longitudinally along the length of the shell and can provide an improved grip for the user or operator of the articulated arthroscopic cutting tool 270.
[0290] Still reference Fig.25The articulated arthroscopic cutting tool assembly may further include a thumb slider, the thumb slider including a slider button 274, a slider clamp 296, and a spring 294 vertically disposed between the slider button 274 and the slider clamp 296. The slider button 274 may include a raised top surface at the distal end of the button and a ridged top surface at the proximal end of the button. The inner surface (i.e., the lower side) of the upper shell 286 may include a plurality of notches (in the lower side) disposed on either side of the rectangular opening 290. Fig.25 The notch can be engaged with a cylindrical pin 275 near the slider button 274 so that the slider button 274 can be locked at different positions along the rectangular opening 290 (i.e., by pushing the slider button 274 downward (thereby compressing the spring 294), sliding the slider button 274 to the desired position, and releasing the slider button 274 so that the pin 275 engages with the notch in the upper shell 286). This position locking mechanism can enable the curved oval blade 278 to be locked at different inclination angles relative to the longitudinal axis of the articulating arthroscopic cutting tool 270.
[0291] Fig.26 A perspective view of a handle 272 of an articulating arthroscopic cutting tool assembly according to aspects of an embodiment of the present invention is shown. Generally speaking, the thumb button 274 protrudes slightly outward from a rectangular opening 290 in the handle top shell 286. A circular hole 298 formed by the top shell member 286 and the bottom shell member 288 of the handle 272 allows the linear stator shaft 276 to be installed in the handle 272.
[0292] Fig. 27 A perspective view of a linear stator shaft 276 of an articulating arthroscopic cutting tool assembly according to aspects of an embodiment of the present invention is shown. In general, the linear stator shaft 276 includes: a cylindrical rod 300; a rectangular groove 302 cut longitudinally along the cylindrical rod 300; a reduced diameter portion 304 along the cylindrical rod 300 near the proximal end of the cylindrical rod 300; and a circular ring 306 protruding vertically from the distal end of the cylindrical rod 300. In some embodiments, the reduced diameter portion 304 can facilitate clamping in the handle 272 (the handle may include corresponding internal notches to interface with the reduced diameter 304, thereby preventing distal, proximal, or circumferential movement of the linear stator shaft 276 relative to the handle 272). In some embodiments, the circular ring 306 can form part of a hinge or attachment for the curved oval blade 278.
[0293] Fig.28A perspective view of the distal end of an articulating arthroscopic cutting tool assembly 270 is shown in accordance with aspects of an embodiment of the present invention. In general, a linear stator shaft 276 may be connected to a curved oval blade 278 at a hinge formed by a ring 306 in the linear stator shaft 276, which is attached to two rings 320 extending from the curved oval blade 278.
[0294] Fig.29 A perspective view of a curved oval blade 278 of an articulating arthroscopic cutting tool assembly 270 according to aspects of embodiments of the present invention is shown. In general, the curved oval blade 278 can include an oval ring 310 and at least three crossbars 312, 314, 316 spanning the top surface of the oval ring 310. In some embodiments, a circular ring 318 can extend vertically from a first crossbar 312, while two circular rings 320 can extend vertically from a second crossbar 314. The top edge of the ring 310 can be curved, while the bottom edge of the ring can include a curved cutting surface that includes a surgically sharp edge 322. In some embodiments, the oval ring 310 can be thicker at the narrow end of the oval ring.
[0295] In some embodiments, the surgeon or user may utilize additional sterile components suitable for easy use in a surgical setting, which may include a suitable hemostatic barrier, a suitable cover patch, and / or an organic glue.
[0296] In some embodiments, a surgeon or user may utilize an acellular matrix material suitable for supporting autologous or allogeneic chondrocytes (eg, as may be suitable for implantation into an articular surface defect).
[0297] In some embodiments, the surgeon or user may utilize a suitable hemostatic barrier, which may be or include, for example Hemostatic barrier.
[0298] In some embodiments, the surgeon or user may utilize a suitable cover patch, which may be or include Cover the patch.
[0299] In some embodiments, the hemostatic barrier (e.g., hemostatic barrier) and / or covering patch (e.g. The cover patch may include an adhesive, such as a tissue adhesive, which in some embodiments may be an organic glue (e.g., Organic glue). In some embodiments, the adhesive may be applied (eg, as a covering) so that the resorption time is increased.
[0300] In some embodiments, the hemostatic barrier (e.g., hemostatic barrier) and / or covering patch (e.g. covering patch), and in particular with an adhesive (e.g., which may include The organic glue-treated cover patch may be supplemented with aprotinin (eg, in a manner and / or to an extent that increases the resorption time).
[0301] In some embodiments, both the hemostatic barrier and the cover patch may be a semi-permeable collagen matrix that has been treated to extend the time before the material is resorbed.
[0302] In some embodiments, the instrument system may include a surgical instrument or multiple surgical instruments. In some embodiments, the instrument system may include one or more sleeves (e.g., 1, 2, 3, 4, 5, or 10 or more sleeves). In some embodiments, the instrument system may include a sleeve or multiple sleeves with an inner diameter of about 5 mm to about 20 mm, about 6 mm to about 12 mm, about 7 mm to about 11 mm, about 8 to about 9 mm, or about 10 to 25 mm. In some embodiments, the sleeve may be made of a material selected from the group consisting of plastic, metal, rubber, silicone, fiberglass, and combinations thereof (e.g., composite materials).
[0303] Fig.30 A schematic diagram of a method 330 for preparing a surgical site during arthroscopic surgery using at least one of a ring curette 350, a square curette 400, or a rake curette 430 (e.g., a 3.6 mm rake curette 430) is shown in accordance with aspects of embodiments of the present invention. Generally, method 330 proceeds after method 250 is completed. In general, the steps may include: installing the barrier seal subassembly 94 onto the sleeve 96 and restarting fluid flow (step 331); inserting a cutting tool (which may include a circular curette 350, a square curette 400, or a rake curette 430) into the sleeve 96 and the barrier seal subassembly 94 (step 332); using the cutting tool to scrape, cut, clean and / or remove cartilage 42 within the oval area 52 previously defined by the curved oval blade 278 on the articulating arthroscopic cutting tool 270 (step 334); removing the cutting tool from the sleeve and barrier seal subassembly 94 (step 336); and repeating steps 332 to 336 as needed until the cartilage in the cutting area of the cartilage is completely removed (step 338).
[0304] Fig.31An annular curette assembly 350 is shown in accordance with aspects of embodiments of the present invention. In general, the annular curette assembly 350 includes a handle 352, a shaft 354 coupled to the distal end of the handle 352, and an annular curette blade 356 coupled to the distal end of the shaft 354. In some embodiments, the shaft 354 can include a cylindrical rod having at least two bends 362, 364 such that the distal end of the shaft has an axis that is parallel and eccentric relative to the main longitudinal axis of the shaft. In some embodiments, the annular curette blade 356 can include at least one surgically sharp edge 374.
[0305] Fig.32 A shaft 354 is shown that can be used with a ring curette assembly 350 or a square curette assembly 400 according to aspects of embodiments of the present invention. In general, the shaft 354 includes: a cylindrical rod 358; a flat portion 360 at the proximal end of the cylindrical rod 358 that can be used to facilitate attachment within the handle 352; a first bend 362 in the cylindrical rod 358 near the distal end of the rod such that the rod axis is tilted away from the main longitudinal axis of the cylindrical rod; a second bend 364 in the cylindrical rod further toward the distal end of the rod such that the rod axis is tilted parallel to and eccentrically positioned relative to the main longitudinal axis of the cylindrical rod; a cylindrical portion 366 of reduced diameter near the distal end of the rod; and a recessed opening 368 with a flat inner surface at the distal end of the shaft.
[0306] Fig.33 A perspective view of an annular curette blade 356 according to aspects of an embodiment of the present invention is shown. In general, the annular curette blade 356 may include: a ring 372 in the shape of a hollow right conical frustum; a rounded edge 370 around the greater circumference of the ring 372; a surgically sharp edge 374 around the greater circumference of the ring 372; a cylindrical connecting shaft 376 disposed radially outwardly at the outer wall of the ring 372; and a cylindrical welding shaft 378 disposed coaxially with the connecting shaft 376. In some embodiments, the cylindrical welding shaft 378 may have a smaller diameter than the cylindrical connecting shaft 376, and the cylindrical welding shaft cooperates with the recessed opening 368 so that the distal edge of the shaft 354 abuts the proximal edge of the cylindrical welding shaft 378, thereby allowing the two surfaces to be bonded via welding (e.g., laser welding).
[0307] Still reference Fig.32 and Fig.33In some embodiments, the shaft 354 and the annular curette blade 356 may include or be constructed of stainless steel type 17-4PH (630) conforming to ASTM A564 or equivalent, UNS S17400. In some embodiments, the shaft 354 and the annular curette blade 356 may include or be constructed of one of the following: a metal, a metal alloy, titanium, carbon steel, stainless steel, tool steel, chrome steel, or ceramic. In some embodiments, the weld shaft 378 of the annular curette blade 356 may be disposed within the recessed opening 368 at the distal end of the shaft 354 and may be connected by laser welding.
[0308] Fig.34 A handle assembly 352 is shown that can be used with a ring curette 350, a square curette 400, or a rake curette 430 according to aspects of embodiments of the present invention. In general, the handle assembly 352 can include: a cylindrical body 390; a plurality of ridges 392 on the exterior side and bottom surfaces of the cylindrical body 390, the plurality of ridges being arranged perpendicular to the longitudinal axis of the cylindrical body 390; a flat surface 394 along the top surface of the cylindrical body; and a circular opening 396 in the distal end of the cylindrical body 390. In some embodiments, the handle assembly 352 can include or be constructed of acrylonitrile butadiene styrene (ABS) or other plastic or polymer material or equivalent.
[0309] Fig.35 A square curette assembly 400 is shown in accordance with aspects of embodiments of the present invention. In general, the square curette assembly 400 may include: a handle 402; a shaft 404 coupled to a distal end of the handle 402; and a square curette blade 406 coupled to a distal end of the shaft 404. In some embodiments, the shaft 404 may include a cylindrical rod having at least two bends 408, 410 such that the ends of the shaft have axes that are parallel and eccentric relative to a main longitudinal axis of the shaft. In some embodiments, the shaft 404 may include a Fig.32 In some embodiments, the square curette blade 406 includes at least two surgically sharp edges 412, 414 (eg, Fig.36 shown).
[0310] Fig.36A square curette blade 406 for a square curette assembly 400 according to aspects of an embodiment of the present invention is shown. In general, the square curette blade 406 may include: a ring 416 in the shape of a hollow rounded rectangular prism; at least two surgically sharp edges 412, 414 at the top edge and the bottom edge of the ring at the distal side of the rectangular prism; a cylindrical connecting shaft 422, the cylindrical connecting shaft being disposed outwardly on the outer wall of the ring at a position on the ring opposite to the positions of the two surgically sharp edges; and a cylindrical welding shaft 424, the cylindrical welding shaft being disposed coaxially with the connecting shaft 422. In some embodiments, the cylindrical welding shaft 424 has a smaller diameter than the connecting shaft 422, and the cylindrical welding shaft may be connected to the connecting shaft 422 via a cylindrical welding shaft. Fig.33 The illustrated embodiment is similarly laser welded to shaft 404 .
[0311] Still reference Fig.35 and Fig.36 In some embodiments, the shaft 404 and the square curette blade 406 may include or consist of stainless steel type 17-4PH (630) conforming to ASTM A564 or equivalent, UNS S17400. In some embodiments, the shaft 404 and the square curette blade 406 may include or consist of one of the following: metal, metal alloy, titanium, carbon steel, stainless steel, tool steel, chrome steel, or ceramic. In some embodiments, the weld shaft 424 of the square curette blade 406 may be disposed within the recessed opening 368 at the distal end of the shaft 354 and may be connected by laser welding.
[0312] Fig.37 A rake curette assembly 430 is shown in accordance with aspects of embodiments of the present invention. In general, the rake curette assembly 430 may include: a handle 423; a shaft 434 coupled to the distal end of the handle 432; and a rake blade 436 coupled to the distal end of the shaft 434. In some embodiments, the shaft may include a cylindrical rod that tapers to a smaller diameter near the distal end of the shaft 434. In some embodiments, the rake blade 436 may include a tapered wedge having at least one surgically sharp edge 454. In some embodiments, the rake blade 436 may be disposed such that it points perpendicularly and radially away from the longitudinal axis of the shaft 434, and such that the surgically sharp edge 454 is disposed perpendicular to the longitudinal axis of the shaft 434, and thus, the rake curette constitutes a cross-axe-like tool rather than an axe-like tool.
[0313] Fig.38A rake shaft 434 for a rake curette assembly 430 according to aspects of embodiments of the present invention is shown. The rake shaft 434 includes: a cylindrical shaft 440; a flat portion 442 at the proximal end of the shaft for attachment within the handle 432; a tapered portion 444 where the diameter of the cylindrical shaft 440 gradually decreases toward the distal end of the shaft; and a cylindrical welded shaft 446 of further reduced diameter coaxially disposed within the tapered portion 444 of the shaft 434.
[0314] Fig.39 A rake blade 436 for a rake curette assembly 430 is shown in accordance with aspects of embodiments of the present invention. In general, the rake blade 436 may include a wedge-shaped body 450 that decreases in thickness as depth increases, a rounded top portion 456 having a cylindrical opening 452 for laser welding, and a surgically sharp edge 454 at the end of the wedge-shaped body.
[0315] Still reference Fig.38 and Fig.39 In some embodiments, the shaft 434 and the rake head blade 436 may include or consist of stainless steel type 17-4PH (630) conforming to ASTM A564 or equivalent, UNS S17400. In some embodiments, the shaft 434 and the rake head blade 436 may include or consist of one of the following: metal, metal alloy, titanium, carbon steel, stainless steel, tool steel, chrome steel, or ceramic. In some embodiments, the cylindrical welding shaft 446 of the shaft 434 may be inserted into the cylindrical opening 452 of the rake head blade 436 and may be connected by laser welding.
[0316] Fig.40 A schematic diagram of a method 460 for preparing a cell-seeding matrix composition for use during arthroscopic surgery according to various aspects of an embodiment of the present invention is shown. In general, method 460 may include: selecting a matrix cutter size to match a surgical site, the surgical site being prepared by cutting and removing cartilage surrounding a defect or damage using a surgical cutting tool in the previous method 330 (step 462); placing a cell-seeding support matrix on a cutting mat with cells on the matrix facing upward (step 464); placing the selected matrix cutter on the cell-seeding support matrix with a surgically sharp edge facing downward (step 466); applying a downward force on the top side of the matrix cutter using at least one of a hand, a mallet, a hammer, and / or other tool (step 468); and removing the matrix cutter and removing the uncut portion of the cell-seeding support matrix (step 470). In some embodiments, the remaining cut portion of the cell-seeding support matrix may include an oval shape or other shape that matches the shape of the matrix cutter.
[0317] Fig.41 A shows a view showing the preparation of a cell seeding support matrix composition according to various aspects of an embodiment of the present invention. In this view, a portion of a cell seeding support matrix 482 is placed on a cutting mat 480 with the cell seeding side facing up; a matrix cutter 484 is placed on top of a cell seeding support matrix 462 with the blade side facing down; and an operator holds a mallet 486.
[0318] Fig.41 B shows a view showing the preparation of a cell seeding support matrix composition according to aspects of an embodiment of the present invention. In this view, the mallet and matrix cutter 484 are in contact at position 488, downward force is being applied by the mallet 486, and a pair of tweezers 490 can be seen nearby.
[0319] Fig.41 C shows a view showing the preparation of a cell seeding support matrix composition according to various aspects of an embodiment of the present invention. In this view, the uncut portion of the cell seeding support matrix 482 has been removed from the cutting pad 480, leaving a cut portion 492 of the matrix whose shape matches the matrix cutter 484. Forceps 490 can be used to manipulate the cell seeding support matrix sheets 482, 492.
[0320] Fig.42 A top-down perspective view of a matrix cutter 500 according to various aspects of an embodiment of the present invention is shown. In general, the matrix cutter 500 may include: an elliptical cylinder body 502; an inner hole 504, which is shaped as a stadium-shaped hole aligned parallel to the semi-long axis of the elliptical cylinder body 502 and longitudinally aligned parallel to the longitudinal axis of the elliptical cylinder body 502; a flat top surface 506 of the elliptical cylinder body; at least two flat gripping notches 508 at the relative outer sides of the elliptical cylinder body; and a surgically sharp edge 510 around the bottom circumference of the elliptical cylinder body 502. In some embodiments, the matrix cutter 500 may include or be composed of stainless steel type 17-4PH (630), UNSS17400 conforming to ASTM A564. In some embodiments, the matrix cutter 500 may include or be composed of one of the following items: metal, metal alloy, titanium, carbon steel, stainless steel, tool steel, chrome steel or ceramic. In some embodiments, dimensions or other information may be etched or printed on the flat top surface 506. The inner hole 504 may also be shaped as an oblong or oval.
[0321] Fig.43A bottom-up perspective view of a matrix cutter 500 is shown in accordance with aspects of embodiments of the present invention. A surgically sharp edge 510 is visible along the bottom circumference of the cutter body 502. In some embodiments, a flat grip notch 508 may be used to hold or manipulate the matrix cutter 500.
[0322] Fig.44 A schematic diagram of a method 520 for implanting a cell-seeded matrix composition according to various aspects of an embodiment of the present invention is shown. In general, the method 520 may include: stopping the flow of fluid and removing the baffle seal subassembly (step 521); drying the surgical site where cartilage was previously cut and removed by aspiration, drainage, and using a first smear swab to clean and dry the surgical site (step 522); using forceps to grasp a piece of previously cut cell-seeded support matrix by grasping the edges of the matrix (step 524); placing the cell-seeded support matrix across the delivery tip of the matrix shuttle device so that the matrix is within the contour at the delivery tip and the cell-containing side of the matrix is facing away from the delivery tip (step 526); using a smear tool to spread the fibrin The invention relates to a method of applying fibrin glue to the surgical site (step 527); inserting the matrix shuttle device into the cannula at the surgical site (step 528); depressing the plunger on the matrix shuttle device to extend at least one antenna-shaped object from the delivery end of the matrix shuttle device to push the cell-seeding support matrix out and onto the surgical site (step 530); removing the matrix shuttle device from the cannula (step 532); if necessary, using a second smear swab to reposition the cell-seeding support matrix, and using the second smear swab to apply fibrin glue around the edge of the cell-seeding support matrix at the surgical site (step 534).
[0323] Fig.45 A perspective view of a substrate shuttle device 540 is shown with deployment wings 548 extended in accordance with aspects of embodiments of the present invention. Fig.46 A perspective view of a substrate shuttle device 540 is shown with deployment wings 548 retracted in accordance with aspects of embodiments of the present invention. Fig.45 and Fig.46 In general, the matrix shuttle device 540 includes: a shuttle body 542; a delivery tip 544 at the distal end of the shuttle body 542; a plunger 554 disposed longitudinally within the shuttle body 542 and protruding outwardly from the proximal end of the shuttle body 542, having a flat disk portion 556 (e.g., a thumb rest or flange) at the proximal end of the plunger 554; at least two deployment wings 548 disposed within the delivery tip 544 and attached to the plunger 554; at least two holes 550 on the distal surface of the delivery tip 544; a spring 558 (shown in Fig.49), the spring is longitudinally disposed inside the shuttle body 542 and attached to the plunger 554; and one or more finger grips 552, the finger grips being disposed at the proximal end of the shuttle body 542. In some embodiments, the plunger 554 is pushed longitudinally into the shuttle body 542 so that the at least two deployment wings 548 extend outward through the at least two holes 550 of the delivery tip. In some embodiments, the proximal end of the spring 558 may be positioned or biased against the middle portion of the plunger 554 (e.g., positioned to contact the cylindrical body 560). In some embodiments, the distal end of the spring 558 may be positioned or biased against the inner surface of the shuttle body (e.g., the inner surface of the shells 562, 564). Pushing and releasing the plunger 554 compresses and stretches the spring 558 in the longitudinal direction, respectively. In some embodiments, when the plunger is released, the spring retracts the at least two deployment wings into the at least two holes.
[0324] In some embodiments, the spring 558 may be made of stainless steel or type 302 stainless steel and / or other metals. In some embodiments, the spring 558 may be about 1.25 inches in length (or between about 1 inch and 2 inches, or between about 1 inch and 1.5 inches, or between about 1.1 inches and 1.3 inches, or between about 1.2 inches and 1.4 inches in length). In some embodiments, the outer diameter (OD) of the spring may be about 0.36 inches (or between about 0.3 inches and 0.4 inches, or between about 0.25 inches and 0.5 inches), and its inner diameter may be about 0.298 inches (or between about 0.2 inches and 0.3 inches, or between about 0.2 inches and 0.4 inches, where the inner diameter is smaller than the inner diameter of the spring).
[0325] Fig.47 A side view of a delivery tip 544 of a matrix shuttle device 540 with a cell seeding support matrix 492 placed across the delivery tip 544 is shown according to aspects of embodiments of the present invention. In some embodiments, the cell seeding support matrix 492 can be cut using a matrix cutter according to method 460 and can be shaped to resemble an oval or other shape. The arrows indicate the placement of the cell seeding support matrix 492 across the delivery tip 544. In some embodiments, the delivery tip 544 can also include: a cylindrical portion 543, which is connected to the shuttle body 542 at the proximal end of the delivery tip 544; a tapered portion 545, which terminates in a flat edge 549 at the distal end of the delivery tip 544; and a contoured flange 547 spanning the top and distal end of the delivery tip 544, the contoured flange comprising an elliptical or oblong shape.
[0326] Fig.48A side view of a matrix shuttle device 540 is shown with deployment wings 548 extended and plunger 554 squeezed to deliver a cell seeding support matrix 492 according to aspects of embodiments of the present invention. The arrow near the plunger 554 indicates that the plunger 554 is pushed into the matrix shuttle device body 542. In some embodiments, the operator can use the thumb to push the plunger 554 and the flat disk portion 556 while using one or more other fingers to pull the finger grip 552. When the plunger 554 is pushed, in some embodiments, this may cause the deployment wings 548 to extend from the holes 550 at the distal end of the delivery tip 544. In some embodiments, the extension of the deployment wings 548 can push the cell seeding support matrix 492 away from the delivery tip 544.
[0327] refer to Fig.47 and Fig.48 In some embodiments, the motion described above can allow the cell seeding support matrix to be delivered to a surgical site as described in step 530 of method 520, wherein the surgical site can be prepared by method 330. The shape of the tapered portion 545 at the distal end of the matrix shuttle device 540 allows for minimization of the surface area to reduce the likelihood that the cell seeding support matrix 492 will adhere to the matrix shuttle device 540 and potentially be damaged during delivery from the matrix shuttle device 540.
[0328] Fig.49 A perspective exploded view of a portion of a matrix shuttle device 540 according to various aspects of an embodiment of the present invention is shown. In addition to the portions described above, in some embodiments, the shuttle body may also include two shells 562, 564. In some embodiments, the plunger 554 includes: a cylindrical body 560; a flat disk portion 556 at the proximal end of the cylindrical body 560; and a recessed portion having a protruding pin 568 at the proximal end of the cylindrical body 560. In some embodiments, the protruding pin 568 includes a small cylinder disposed perpendicular to the longitudinal axis of the cylindrical body 560 and a rounded knob having a diameter larger than the diameter of the small cylinder. In some embodiments, the protruding pin 568 with the rounded knob can be inserted into the circular hole 572 of the deployment wing 548 (shown in Fig.50 ) so as to attach the deployment wing 548 to the plunger 554 so that movement of the plunger can cause the deployment wing 548 to be actuated.
[0329] Still reference Figures 45 to 49 , the matrix shuttle body 542 and plunger 554 may include or be constructed of acrylonitrile butadiene styrene (ABS) or other polymer or plastic material or equivalent.
[0330] Fig.50A perspective view of a deployment wing 548 for use with a matrix shuttle device 540 according to various aspects of an embodiment of the present invention is shown. In general, the deployment wing includes: a U-shaped body (570); at least two wing arms (574), the wing arms including cylindrical rods extending in parallel from the U-shaped body (570) and curving outwardly away from the U-shaped body (570); at least two rounded tips (576) at the distal ends of the at least two wing arms (574); and a circular hole (572) at the proximal bottom of the U-shaped body. In some embodiments, the deployment wing 548 may include or be composed of silicone or ethylene propylene diene monomer (EPDM) rubber or other polymers, plastics, or equivalent materials. When the two wing arms 574 are deployed (or extended) to push the cell seeding support matrix 492 away from the matrix shuttle device 540, the two rounded tips 576 help prevent damage to the cell seeding support matrix 492 (and / or the cells disposed thereon).
[0331] like Fig.49 and Fig.50 As shown, each of the rounded tips 576 is angled outwardly relative to the centerline 577 of the deployment wing 548 at an angle of about 1 degree to about 20 degrees (e.g., about 5 degrees to 10 degrees, about 3 degrees to 20 degrees, about 5 degrees to 18 degrees, about 6 degrees to 12 degrees, about 15 degrees to 20 degrees, about 10 degrees to 15 degrees, about 2 degrees to 6 degrees, about 3 degrees to 30 degrees, between 1 degree and 45 degrees, and other subranges therebetween) . In some embodiments, when the deployment wing 548 is stored in the shuttle body, the rounded tips 576 are compressed radially inwardly by the inner surfaces of the shells 562, 564. When the deployment wing 548 is deployed externally, the inherent elasticity of the deployment wing 548 pushes the rounded tips radially outward (e.g., as Fig.48 ), thereby pushing the support matrix 492 away from the distal delivery tip portion 544 of the matrix shuttle delivery device 540. In other words, when the rounded tips 576 are not compressed inwardly by the inner surface of the shuttle device 540 (that is, when they are in the deployed position), they will expand outwardly to their uncompressed shape (that is, Fig.50 By pushing plunger 554 distally, rounded tip 576 not only expands distally, but also expands radially outward, thereby facilitating release of support matrix 492 from tapered portion 545. Furthermore, the radially outward motion of rounded tip 576 (i.e., in addition to the distal movement of rounded tip 576) facilitates expansion of support matrix 492 prior to application at a target site.
[0332] Fig.51A perspective view of an application tool 580 according to various aspects of an embodiment of the present invention is shown. In general, the application tool 580 may include: a cylindrical rod 582; an application swab 584, which is attached to one end of the cylindrical rod 582 by an adhesive; and an application tip 586, which is attached to the other end of the cylindrical rod 582 by an adhesive. In some embodiments, the application swab 584 may include cotton or polyurethane foam or other similar soft absorbent materials. In some embodiments, the application tip 586 may include soft silicone or other similar compliant materials. In some embodiments, the cylindrical rod 582 may include a plastic material. In some embodiments, the adhesive may include Loctite 4011 glue.
[0333] Fig.52 A schematic diagram of an arthroscopic surgical method 600 for repairing a cartilage defect is shown in accordance with aspects of embodiments of the present invention. In general, method 600 may include: forming an incision at a joint near a cartilage defect on a patient's body (step 602); inserting a sleeve assembly into the incision (step 604); measuring the cartilage defect at the joint using an arthroscopic measurement tool inserted through the sleeve (step 606); preparing a cartilage area around the cartilage defect (step 608); preparing a cell-seeded matrix composition and using a matrix cutter tool to cut a portion of the cell-seeded matrix composition to match the shape of the prepared cartilage area (step 610); placing the portion of the cell-seeded matrix composition across a delivery tip of a matrix shuttle delivery device (step 612); inserting the matrix shuttle delivery device through the sleeve (step 614); depressing a plunger on the matrix shuttle delivery device to extend at least two deployment wings from the delivery tip, thereby pushing the portion of the cell-seeded matrix composition away from the delivery tip and onto the prepared cartilage area (step 616); and removing the matrix shuttle delivery device from the sleeve (step 618).
[0334] In some embodiments, step 608 may include: using a first cutting tool to define a cartilage region surrounding the cartilage defect; and using one or more additional surgical cutting tools to scrape, cut, clean and / or remove cartilage within the cartilage region defined by the first cutting tool. In some embodiments, the cell seeding matrix composition of step 610 may include chondrocytes seeded on one side of the bioabsorbable matrix. In some embodiments, in step 610, the side of the cell seeding matrix composition having chondrocytes faces away from the delivery end of the matrix shuttle delivery device. In some embodiments, method 600 may include the following additional steps: applying fibrin glue to the prepared cartilage before delivering the cell seeding matrix composition; applying fibrin glue around the edge of the cell seeding matrix composition after delivering the cell seeding matrix composition to the prepared cartilage; removing the cannula from the incision; and closing the incision by surgery.
[0335] In some embodiments, the device system may include cells seeded on the surface of the matrix. In some embodiments, the cells may include allogeneic chondrocytes. In some embodiments, the cells may include cells obtained from a non-human source.
[0336] In some embodiments, the instrument system may include one or more tools for measuring cartilage defects, cutting cartilage and preparing surgical site, cutting cell seeding support matrix and delivering and implanting cell seeding support matrix. In some embodiments, the instrument system may include custom cutters (including, for example, articulated arthroscopic cutting tools, annular curettes, square curettes and rake-shaped curettes), matrix cutters, measuring tools and / or cutting blocks. Other tools and materials that surgeons or users can use during surgery may include scissors, razor blades, scalpels, surgical mallets and / or cutting pins.
[0337] In some embodiments, the instrument system may include a device that is or includes a custom cannula assembly. In some embodiments, the inner diameter of the custom cannula assembly provided in the kit may be in the range of about 15 mm to about 20 mm. The custom cannula assembly may include an obturator, a barrier seal subassembly, and / or a cannula body.
[0338] In some embodiments, the instrument system may include one or more tools for fastening an implantable composition to a surgical site. In some embodiments, the instrument for fastening an implantable composition may include one or more probes. In some embodiments, the instrument for fastening an implantable composition may include a smearing tool.
[0339] In some embodiments, additional materials and tools that a surgeon or user may use to perform the methods of the present disclosure may include forceps, tweezers, Adson clamps, neurosurgical patties, sutures, sterile culture dishes, sterile flasks, sterile solutions, epinephrine and / or sterile saline.
[0340] It will be appreciated by persons skilled in the art that numerous variations and / or modifications may be made to the invention as shown in the specific embodiments without departing from the spirit or scope of the invention as broadly described.
[0341] All publications, patent applications, patents and other references mentioned herein are incorporated by reference in their entirety. In addition, materials, methods and embodiments are illustrative only and are not intended to be limiting. Unless otherwise defined, all technical terms and scientific terms used herein have the same meanings as those of ordinary skill in the art to which the present disclosure pertains. Although methods and materials similar to or equivalent to the methods and materials described herein can be used in the practice or testing of the present disclosure, suitable methods and materials are described herein.
[0342] Example
[0343] Embodiment 1: Defect preparation
[0344] This embodiment (Example 1) describes the use of the technology provided in the present disclosure to prepare the knee cartilage defect in the surgical site to be treated. First, the surgical site can be rinsed and cleaned with isotonic saline. The cartilage defect and the cartilage surrounding the defect can be physically and visually assessed via an arthroscopic device (e.g., an arthroscopic camera), which is inserted into the site via a sleeve 96 positioned in a first surgical site adjacent to the defect. Discoloration, irregular surface areas, lack of normal elasticity, cartilage thinning and / or cartilage instability and damage should be noted. After the inspection, the size of the defect should be measured using an arthroscopic measuring probe 210, which is a tool inserted into a sleeve 96 disposed at the surgical site with an extendable and rotatable ruler 218 at its distal end. The surgeon or operator should use the markings 232 on the ruler 218 to measure the size of the defect in order to select the appropriate cutting tool in the next step.
[0345] After measuring the defect, a set of surgical cutting tools, such as, but not limited to, inserted into a cannula 92 in a second surgical site, can be used to outline and delineate the cartilage area surrounding the defect. The first tool is an articulated arthroscopic cutting tool 270 having a curved oval blade 278 at the distal end. The size of the blade 278 should be selected based on the measurement results so that the blade can completely surround the defect. The operator or surgeon can use the thumb slider 274 on the cutting tool 270 to adjust the angle of inclination of the blade 278, and then press the blade into the cartilage to form a clear outline 52 in the cartilage.
[0346] Next, the defect should be removed, down to the subchondral bone and to the periphery, until the vertical wall of the healthy stable cartilage 52 surrounds the defect. The second, third and / or fourth surgical cutting tools can be used for removal. These tools may include an annular curette 350, a square curette 400 and / or a rake curette 430. Each of these tools can be inserted through the sleeve 92, has at least one surgically sharp cutting edge or blade mounted at the end of the shaft, and has a handle protruding outside the sleeve. The user or operator can manipulate these cutting tools to position the surgically sharp cutting edge at the defect site to cut or scrape the cartilage. All damaged and fibrous tissues on the defect bed should be removed. It should be noted that the removal of healthy cartilage outside the contour formed by the shape defined by the articulated arthroscopic cutting tool 270 is minimal. It should also be noted that penetration of the subchondral bone should be avoided. The resulting exposed area of subchondral bone 54 and surrounding stabilizing cartilage 42 can form a clearly defined shape 52, such as an oval, which matches the shape of the curved blade of the articulated arthroscopic cutting tool. The fluid of the knee joint can be drained through an incision or via suction to prepare for the delivery of the implant to the defect in the surgical site. Kitners ("peanuts") can also be used to dry excess fluid around the defect, thereby effectively absorbing excess fluid from the cartilage defect. For punctate bleeding in the subchondral bone, hemostasis can be achieved by applying pressure with a neurosurgical hemostatic pad soaked with diluted epinephrine (e.g., 1cc of 1:1000 epinephrine diluted with 20cc sterile saline, etc.), or by applying a fibrin sealant at the bleeding point.
[0347] Embodiment 2: Preparation of support matrix for cell seeding
[0348] Before delivering and implanting the surgical site, the cell seeding support matrix should be prepared by cutting the cell seeding support matrix into suitable size and shape. In the above embodiment 1, the defect position is prepared by forming the exposed area of subchondral bone and the shape 52 of the clear definition of surrounding stable cartilage. The next step is to prepare a part of the shape matching with the prepared defect position of the cell seeding support matrix, so that the part can be delivered to cover the subchondral bone with minimum gap or overlapping. The matrix cutter 500 that the size and shape are matched with the prepared position can be selected. A slice of cell seeding support matrix 482 can be placed on the cutting pad 480 in the upward mode of cells. Cutting pad 480 can include soft or compliant material (such as silicone or rubber). Cells should be upward, and should minimize contact with the cell seeding surface to avoid damage to cells. Then matrix cutter 500 is placed on the cell seeding support matrix 482 in the downward mode of blade side 510. Then, user or operator uses at least one in hand, hammer, mallet 486 and / or other tools to apply downward force to the top surface 506 of matrix cutter 500.Downward force makes the blade 510 of matrix cutter 500 cut into the cell seeding support matrix 482 in the mode that is similar to cookie cutter cuts out biscuits from a piece of dough.Remove matrix cutter 500 then, and the part that is cut into the same shape 492 as matrix cutter 500 of cell seeding support matrix can be taken by tweezers 490 and / or other manipulation tools.The manipulation of cell seeding support matrix should be mainly carried out at the cutting edge, to minimize the damage to cell.
[0349] Embodiment 3: Delivery of cell-seeded support matrices using a matrix shuttle delivery device
[0350] After the matrix cutter tool 500 presented in the use embodiment 2 is prepared for cell seeding support matrix 492 (by using the matrix cutter 500 to cut the described cell seeding support matrix), the cell seeding support matrix 492 can be delivered to the surgical defect part prepared in the embodiment 1.User or operator can use tweezers to grasp one or more edges of the cell seeding support matrix 492 gently to grab the prepared cell seeding support matrix 492, note to minimize the contact with the matrix interior and manipulate the matrix gently, so as to minimize the damage to the cell.Then the distal end portion 544 of the matrix shuttle delivery device 540 can be delivered across the matrix to carefully place the cell seeding support matrix 492, wherein the cell seeding side is upward.Delivery end portion 544 has the profile 547 that is embossed as a depression, so that it adapts to the shape and size of the prepared cell seeding support matrix.Can obtain the matrix shuttle delivery device of different sizes, to mate with the cell seeding support matrix sheet of different sizes. The delivery tip portion also has a narrow flat tip region 549 at its farthest distal end to minimize the contact area between the device and the cell seeding support matrix 492. The cell seeding support matrix 492 is maintained in contact with the matrix shuttle delivery device 540 by capillary forces due to moisture between the shuttle device and the matrix without the need for an additional attachment mechanism.
[0351] The matrix shuttle delivery device 540 with the cell seeding support matrix 492 placed on the delivery end 544 is then inserted into the sleeve 92 at the surgical site. Then, the user or operator should position the delivery end 544 by moving and rotating the matrix shuttle delivery device 540 so that the cell seeding support matrix 492 is closely aligned with the prepared defect 52. Then, while using the finger grip to provide a reaction force, the user or operator pushes the plunger 556 on the matrix shuttle delivery device 540 into the body of the matrix shuttle delivery device 540. When pushing the plunger 556, at least two deployment wings 548 in the delivery end 544 protrude outward from at least two holes 550 and push the bottom cell-free side of the cell seeding support matrix 492. The end 576 of the deployment wing 548 is rounded and has a small radius to minimize the contact area with the cell seeding support matrix 492. The cell seeding support matrix 492 is then pushed away from the delivery end 544 of the matrix shuttle delivery device 540 and pushed onto the prepared defect 52. The cell seeding side of the matrix should contact the exposed subchondral bone at the prepared defect. The user or operator can use the smear tool 580 to gently reposition the cell seeding support matrix 492 so that it is well aligned in the prepared defect 52.
[0352] Embodiment 4: Fastening the cell-seeding support matrix to the cartilage defect
[0353] This example (Example 4) describes a method for securing a cell-seeded support matrix 492 to a defect within a surgical site. The cell-seeded support matrix 492 may be secured using a fibrin glue securing step, which may be performed after arthroscopic delivery of the cell-seeded support matrix 492 to the defect in the patient. After the cell-seeded support matrix 492 is inserted into the defect with the cell-seeded side of the implant facing the defect, a fibrin sealant (such as A fibrin-based adhesive (available from Baxter, Austria) is applied to the edge (ie, perimeter) of the implant. Gentle pressure may then be applied using an application tool 580 or another tool.
[0354] The safety of the implant should be tested by fully flexing and extending the knee multiple times, and then checking the implant to ensure that it remains in place. The joint can then be irrigated to remove any loose particles of bone or cartilage remaining within the site. Care should be taken to ensure that the implant is protected and does not fall out during irrigating. The wound can then be closed using standard techniques known to those skilled in the art.
[0355] In general, the above embodiments describe how to use the embodiments of the present invention to perform arthroscopic surgery at the knee joint to repair cartilage defects. Use an arthroscopic measurement tool 210 to measure the defect site. Select and use a cutting tool 270 of appropriate size to cut out the outline around the defect. Use one or more surgical cutting tools to prepare the defect site to remove damaged cartilage and form a clearly defined area 52 of exposed subchondral bone surrounded by healthy cartilage. Prepare a portion of the cell seeding support matrix 492 by cutting the cell seeding support matrix 492 with a matrix cutter 500 to match the size and shape of the prepared defect site 52. Use a matrix delivery shuttle device 540 to deliver the cell seeding support matrix 492 to the defect site to minimize contact or damage to the cells. Then use fibrin glue to fasten the cell seeding support matrix 492, clean and rinse the joint, and close the wound site.
[0356] Embodiment 5: Cell Viability Laboratory Test (Bench Testing)
[0357] In this example (Example 5), the delivery methods described in Examples 3, 4, and 5 were compared based on their effects on cell number and viability after delivery to a defect within a surgical site in simulated knee tissue. This experiment was performed using a human cadaver knee model. Positive controls included conditions where the cell-seeded matrix was not delivered to the site by any method, and conditions where the cell-seeded matrix was delivered to the site using conventional open surgical techniques.
[0358] Delivery of cell-seeded support matrix implants via the methods, tools and devices of the present disclosure yielded unexpected and surprising results of qualitatively measured increases in cell number and cell viability values compared to traditional surgical approaches.
[0359] As a qualitative visual measure of cell viability, cellular metabolic activity was determined by staining the cells on the matrix with 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) and visually inspecting cells that were positive for insoluble formazan, a dark-colored conversion product that marks actively respiring cells. Compared to other methods tested, matrices delivered using the current methods and tools retained the highest number of metabolically active cells that approached the non-delivered positive control matrix. The MTT assay also demonstrated the importance of minimizing contact and manipulation of the cell seeding support matrix in order to achieve the highest cell viability in the cell seeding support matrix.
[0360] Conventional methods for implanting MACI (and / or cell seeding support matrix 492) result in cell viability of less than 4% when using an arthroscopic approach and less than 40% when using an open technique. (See Biant et al. (Biant, LC, Simons, M., Gillespie, T., and McNicholas, MJ, 2017. Cell viability in arthroscopic versus open autologous chondrocyte implantation. The American Journal of Sports Medicine, 45(1), pp. 77-81)).
[0361]
[0362]
[0363] Table 1 – Laboratory test results
[0364] Table 1 includes laboratory test results achieved using the device and method described herein. The table includes a summary of the minimum cell number (MCN) and cell viability results in various exemplary steps, including delivery of cell seeding matrix 492 via shuttle delivery device 540, manipulation of cell seeding matrix 492 with silicone tip 586 (also shown as smear tip in some embodiments) and manipulation of cell seeding matrix 492 with sponge tip 584 (also shown as smear swab in some embodiments). MCN and cell viability of control experiments are also reported, and the control experiment applies finger pressure to cell seeding matrix 492 for 30 seconds with various pressures (e.g., about 370 grams to about 1635 grams). In each case, the minimum cell number (MCN, as measured by relative fluorescence unit RFU) and cell viability (measured in percentage and evaluated with overall mean value) meet the relevant acceptance criteria (i.e., greater than 5000RFU and greater than or equal to 80% cell viability, respectively). It should be noted that cell viability values are all within the range of 94% and 99%.
[0365] Equivalent solutions
[0366] Those skilled in the art will recognize or be able to ascertain using no more than routine experimentation many equivalents to the specific embodiments of the invention described herein.The scope of the present invention is not intended to be limited to the above description, but rather is set out in the appended claims.
Claims
1. A matrix shuttle delivery device, comprising: a shuttle body, wherein the shuttle body comprises a substantially hollow cylinder; a delivery tip at a distal end of the shuttle body; a plunger disposed longitudinally within the shuttle body and projecting outwardly from a proximal end of the shuttle body; at least two deployment wings disposed within the delivery tip and attached to the plunger; as well as at least two holes on a distal surface of the delivery tip; The plunger is pushed longitudinally into the shuttle body so that the at least two deployment wings extend to the outside through the at least two holes of the delivery tip.
2. The matrix shuttle delivery device of claim 1, wherein the matrix shuttle device further comprises a spring disposed longitudinally within the shuttle body and attached to the plunger.
3. The matrix shuttle delivery device of claim 1, wherein the matrix shuttle device further comprises one or more finger grips disposed at the proximal end of the shuttle body.
4. The matrix shuttle delivery device of claim 3, wherein the one or more finger grips each comprise a rod connected at one end to an outer surface of the shuttle body and extending radially outwardly away from the shuttle body, wherein a distal side of each rod is curved to accommodate a user's finger.
5. The matrix shuttle delivery device of claim 1, wherein the delivery tip comprises: a cylindrical portion connected to the shuttle body at a proximal end of the delivery tip; a tapered portion comprising two sloped sides that converge to a flat surface at a distal end of the delivery tip; and a contoured flange around the distal end of the delivery tip, the contoured flange comprising an elliptical or oblong shape, Wherein a centerline of the contoured flange is substantially parallel to the planar surface at the distal end of the delivery tip.
6. The matrix shuttle delivery device of claim 5, wherein the at least two holes are each positioned on the two inclined sides of the delivery tip such that when the deployment wings are extended, a line connecting the rounded ends of the deployment wings is substantially perpendicular to the flat surface at the distal end of the delivery tip.
7. The matrix shuttle delivery device of claim 1, wherein each of the at least two apertures comprises a diameter that is larger than a diameter of each of the at least two deployment wings.
8. The matrix shuttle delivery device of claim 1, wherein the deployment wing comprises: U-shaped body; at least two wing arms, the at least two wing arms comprising cylindrical rods extending in parallel from the U-shaped body and bending outwardly away from the U-shaped body; at least two rounded tips at distal ends of the at least two wing arms; as well as A circular hole at the proximal bottom of the U-shaped body.
9. The matrix shuttle delivery device of claim 1, wherein the deployment wing comprises at least one member of the group consisting of silicone, ethylene propylene diene monomer (EPDM) rubber, plastic, and a flexible polymer material.
10. The matrix shuttle delivery device of claim 8, wherein the plunger comprises: Cylindrical body; a flat disk portion at a proximal end of the cylindrical body; as well as A recessed portion having a protruding pin at the proximal end of the cylindrical body, The protruding pin includes a small cylinder disposed perpendicularly to the longitudinal axis of the cylindrical body and a rounded knob having a diameter larger than that of the small cylinder.
11. The matrix shuttle delivery device of claim 10, wherein the protruding pin of the plunger passes through the circular hole at the proximal bottom of the U-shaped body of the deployment wing.
12. The matrix shuttle delivery device of claim 1, wherein the plunger and the shuttle body comprise at least one of acrylonitrile butadiene styrene (ABS) or plastic.
13. The matrix shuttle delivery device of claim 3, wherein the shuttle body, the delivery tip, and the finger grip are formed to converge to form two continuous identical shells of the matrix shuttle delivery device.
14. The matrix shuttle delivery device of claim 2, wherein the spring causes the at least two deployment wings to retract into the interior of the at least two apertures when the plunger is released.
15. An arthroscopic measurement probe (210), comprising: A handle (212), the handle comprising a top shell (211) and a bottom shell (213); Adjustment knob (214); Rotary plug (222); Positioning pin (224); Travel arm (226); Sizing tube (216); as well as Flexible ruler (218), wherein the rotating plug, the adjusting knob, the travel arm, the calibrating tube and the flexible ruler are coaxially connected, and The flexible ruler is arranged through the interior of the calibrating tube.
16. The measuring probe of claim 15, wherein the flexible ruler (218) comprises: a cylindrical rod (230), the cylindrical rod comprising polyetheretherketone (PEEK); an inner flexible wire, the inner flexible wire comprising nickel titanium alloy (or Nitinol); as well as a plurality of markings (232) distributed along a length of the outer surface of the cylindrical rod near the distal end of the cylindrical rod (230), The markings (232) include thin lines perpendicular to the longitudinal axis of the cylindrical rod (230) and spaced apart at intervals of 2.5 mm and 5.0 mm.
17. The measuring probe according to claim 15, wherein the calibrating tube comprises: a hollow cylindrical tube (234), the hollow cylindrical tube comprising at least one of stainless steel T304, stainless steel T316 and a split hypodermic injection tube; two slits (236) disposed at the proximal end of the hollow cylindrical tube and positioned at diametrically opposed locations; a curved portion (238) of the hollow cylindrical tube (234) at the distal end, wherein the curve comprises a right angle bend in the tube; and an opening (240) in the distal end of the hollow cylindrical tube (234).
18. The measurement probe of claim 15, wherein the top shell member (211) and the bottom shell member (213) comprise acrylonitrile butadiene styrene (ABS) or other similar plastics.
19. An articulated arthroscopic cutting tool (270), comprising: Handle (272); Thumb Slider (274); Linear stator shaft (276); a curved oval blade (278) connected to the linear stator shaft 276 via an articulated joint (280); a linear drive shaft (292) connected to the thumb slide (274); and a linkage (282) connected to both the linear drive shaft (292) and the curved oval blade (278), wherein movement of the thumb slide (274) causes the curved oval blade (278) to tilt relative to the linear stator shaft (276).
20. The cutting tool of claim 19, wherein the handle (272) comprises: an upper shell (286) comprising a ridged semi-cylinder and a rectangular opening (290) cut longitudinally along the ridged semi-cylinder closer to a distal end of the ridged semi-cylinder; and a lower shell (288), the lower shell comprising a ridged semi-cylinder, wherein the upper shell and the lower shell are closed together to form a complete cylindrical body having a circular opening (298) at the distal end, and A plurality of notches are arranged on the lower side of the upper shell (286) around the rectangular opening (290).
21. The handle of claim 20, wherein the upper shell and the lower shell comprise acrylonitrile butadiene styrene (ABS) or an equivalent plastic.
22. The cutting tool of claim 19, wherein the thumb slide comprises: a slider button (274) comprising a raised top surface at a distal end of the button and a ridged top surface at a proximal end of the button; a slider clamp (296); and a spring (294) attached to the slider button (274) at one end of the spring (294) and to the slider clamp (296) at the other end of the spring (294), and wherein the spring (294) is vertically disposed between the slider button (274) and the slider clamp (296), Wherein a cylindrical pin (275) actuated by the slider button (274) can engage with the plurality of notches on the lower side of the upper shell (286).
23. The cutting tool of claim 19, wherein the linear stator shaft (276) comprises: A cylindrical rod (300); a rectangular groove (302) cut longitudinally along the cylindrical rod; a reduced diameter portion (304) along the cylindrical rod (300) near the proximal end of the cylindrical rod (300); and A circular ring (306) protrudes perpendicularly from the distal end of the cylindrical rod.
24. The linear stator shaft (276) of claim 23, wherein the linear stator shaft comprises stainless steel type 17-4PH (630) conforming to ASTM A564, UNS S17400.
25. The cutting tool of claim 19, wherein the curved oval blade (278) comprises: Oval ring (310); at least three crossbars (312, 314, 316), the at least three crossbars spanning the top surface of the oval ring (310); a circular ring (318) extending perpendicularly from the first crossbar; two circular rings (320) extending perpendicularly from the second crossbar; as well as a curved cutting surface (322) along the bottom circumference of the oval ring, wherein the oval ring is thicker at a narrow end of the oval ring, and Wherein the curved cutting surface comprises a surgically sharp edge.
26. The curved oval blade of claim 25, wherein the curved oval blade comprises stainless steel type 17-4PH (630) conforming to ASTM A564, UNS S17400.
27. A matrix shuttle delivery device comprising: a shuttle body, wherein the shuttle body comprises a substantially hollow cylinder; A delivery tip at the distal end of the shuttle body, the delivery tip comprising: a cylindrical portion connected to the shuttle body at a proximal end of the delivery tip; a tapered portion comprising two sloped sides that converge to a flat surface at a distal end of the delivery tip; and a contoured flange spanning the top of the delivery tip and the distal end, the contoured flange comprising an oval or oblong shape; a plunger disposed longitudinally within the shuttle body and projecting outwardly from a proximal end of the shuttle body, the plunger comprising: Cylindrical body; a flat disk portion at a proximal end of the cylindrical body; and A recessed portion having a protruding pin at the proximal end of the cylindrical body, The protruding pin includes a small cylinder disposed perpendicularly to the longitudinal axis of the cylindrical body and a rounded knob having a diameter larger than that of the small cylinder.
28. The matrix shuttle delivery device of claim 27, further comprising: at least two deployment wings disposed within the delivery tip and attached to the plunger, the deployment wings comprising: U-shaped body; at least two wing arms, the at least two wing arms comprising cylindrical rods extending in parallel from the U-shaped body and bending outwardly away from the U-shaped body; at least two rounded tips at distal ends of the at least two wing arms; and a circular hole at the proximal bottom of the U-shaped body; and one or more finger grips, the one or more finger grips being disposed at the proximal end of the shuttle body, The device also includes: at least two holes, each hole positioned on one of the two angled sides of the delivery tip; and a spring disposed longitudinally within the shuttle body and attached to the plunger, wherein the plunger is pushed longitudinally into the shuttle body such that the at least two deployment wings exit the at least two apertures of the delivery tip, and Wherein when the plunger is released, the spring causes the at least two deployment wings to retract into the interior of the at least two holes.
29. An arthroscopic surgical method for repairing cartilage defects, comprising: forming an incision in the patient's body at a joint adjacent to the cartilage defect; inserting a cannula assembly into the incision; measuring the cartilage defect at the joint using an arthroscopic measurement tool inserted through the cannula; preparing a cartilage area around the cartilage defect; preparing a cell-seeded matrix composition and using a matrix cutter tool to cut a portion of the cell-seeded matrix composition to match the shape of the prepared cartilage region; The delivery tip of the trans-matrix shuttle delivery device places the portion of the cell-seeded matrix composition; inserting the matrix shuttle delivery device through the cannula; depressing a plunger on the matrix shuttle delivery device to extend at least two deployment wings from within the delivery tip, thereby pushing the portion of the cell-seeded matrix composition away from the delivery tip and onto the prepared cartilage region; as well as The matrix shuttle delivery device is removed from the cannula.
30. The method of claim 29, wherein preparing the cartilage region comprises: defining a cartilage region surrounding the cartilage defect using a first cutting tool; as well as One or more additional surgical cutting tools are used to scrape, cut, clean and / or remove cartilage within the cartilage region defined by the first cutting tool.
31. The method of claim 29, wherein the cell-seeded matrix composition comprises chondrocytes seeded on one side of a bioresorbable matrix, and wherein the side of the matrix having chondrocytes faces away from the delivery tip of the matrix shuttle delivery device.
32. The method of claim 29, further comprising: applying fibrin glue to the prepared cartilage prior to delivering the cell-seeded matrix composition; applying fibrin glue around the edge of the cell-seeded matrix composition after delivering the cell-seeded matrix composition to the prepared cartilage; removing the cannula from the incision; and The incision is closed surgically.
33. A sleeve assembly (90), comprising: A sleeve body (96); a barrier seal subassembly (94) disposed proximally of the cannula body, the barrier seal subassembly (94) and the cannula body (96) being coaxially aligned; as well as An obturator (92) is coaxially inserted through both the cannula body (96) and the barrier seal subassembly (94).
34. The assembly of claim 33, wherein the sleeve body (96) comprises: a hollow cylindrical portion (120) comprising a helical thread (126) wrapped around the entire length of an outer surface of the hollow cylindrical portion (120); a lip portion (122) at a proximal end of the hollow cylindrical portion (120), the lip portion (122) comprising a diameter greater than a diameter of the hollow cylindrical portion (120); two projections (128) disposed at diametrically opposite positions on the outer edge of the lip portion (122); and A curved opening (130) at the distal end of the hollow cylindrical portion (120).
35. The cannula body of claim 34, wherein the curved opening (130) is marked by a visible outline around the circumference of the curved opening and by two small visible marks (132) at diametrically opposed locations around the curved opening.
36. The assembly of claim 33, wherein said cannula body (96) comprises a translucent polycarbonate material.
37. The assembly of claim 33, wherein the baffle seal subassembly (94) comprises: A baffle top member (148); a first barrier seal (154), the first barrier seal comprising at least one aperture; a second barrier seal (156), the second barrier seal comprising at least one slit; a third barrier seal (158), the third barrier seal comprising at least one slit; as well as The bottom baffle member (150) Wherein the barrier top member (148), the first barrier seal (154), the second barrier seal (156) and the third barrier seal are all coaxially aligned (or longitudinally aligned, or axially aligned) and stacked parallel to each other.
38. The subassembly of claim 37, wherein the baffle top member (148) comprises: a circular portion (151) comprising a circular hole (154) concentrically disposed therein; a plurality of legs (152) extending vertically from the bottom surface of the circular portion and distributed circumferentially around the circular portion (151); as well as Two notches (112) are arranged around the circular hole (154) at diametrically opposite positions.
39. The subassembly of claim 37, wherein the baffle top member and the baffle bottom member comprise acrylonitrile butadiene styrene (ABS).
40. The subassembly of claim 37, wherein the first barrier seal (154) comprises: Disc (173); a circular hole (176) concentrically disposed at the center of the disk; as well as A plurality of smaller circular holes (174) are circumferentially disposed around the edge of the disk.
41. The subassembly of claim 37, wherein the second barrier seal and the third barrier seal each comprise: Disc (171); three slits (172) in a radial direction from the center of the disk, the three slits being spaced 120 degrees apart from each other; and a plurality of smaller circular holes (170), the plurality of smaller circular holes being arranged along a circumference around the edge of the circular disk (171), The second barrier seal and the third barrier seal are coaxially stacked one next to the other and rotated such that the slits in each seal do not overlap.
42. The subassembly of claim 37, wherein the first barrier seal, the second barrier seal, and the third barrier seal all comprise one of silicone or EPDM rubber.
43. The subassembly of claim 37, wherein the baffle bottom member (140) comprises: a hollow cylindrical portion (150); a flat circular top portion (146); a circular hole (144) concentrically disposed in the flat circular top portion (146); two notches (112) disposed at diametrically opposed positions around the circular hole (144); and Two barrier release clips are disposed at diametrically opposed positions at the distal edge of the hollow cylindrical portion.
44. The subassembly of claim 37, wherein the baffle top member and the baffle bottom member comprise acrylonitrile butadiene styrene (ABS) or an equivalent.
45. The assembly of claim 33, wherein the occluder comprises: a handle portion (100) at a proximal end of the occluder; A shaft portion (104); as well as a tip portion (106) at the distal end of the obturator, The handle portion (100) comprises a rounded dome structure, wherein the dome structure comprises strips (102) with a constant thickness arranged parallel and perpendicular to the axis direction. The shaft portion (104) comprises a cylindrical rod connecting the handle portion and the head portion, wherein the tip portion (106) includes a conical tip at a distal end and a plurality of support fins (108), and Wherein the handle portion, the shaft portion and the tip portion are all coaxially aligned (or longitudinally aligned, or axially aligned).
46. The assembly of claim 33, wherein the occluder comprises: Two or more rotation protrusions (110), the two or more rotation protrusions protruding from the bottom of the distal side of the handle portion (100) and arranged at diametrically opposite positions; as well as One or more concave portions (180) in the dome structure of the handle portion.
47. The assembly of claim 33, wherein the occluder comprises acrylonitrile butadiene styrene (ABS) or an equivalent.
48. An arthroscopic surgical method (10), comprising: Making incisions at joints on the patient's body; inserting a cannula assembly into the incision; measuring the cartilage defect at the joint using an arthroscopic measurement tool inserted through the cannula; preparing a cartilage area around the cartilage defect; as well as A cell-seeded matrix composition is prepared and a matrix cutter tool is used to cut a portion of the cell-seeded matrix composition.
49. The method of claim 48, wherein preparing the cartilage region further comprises: Using a cutter tool to score an area in the cartilage surrounding the defect; Using one or more cutting tools and scraping tools to clean the scored area to expose the bone surface in a defined area or shape; as well as Use a smear tool to dry the exposed bone area.
50. The method of claim 48, wherein the joint site may include one of a medial femoral condyle, a lateral femoral condyle, a patella, or a trochlea.
51. The method of claim 48, wherein cleaning the scored area further comprises using at least one of a ring curette, a square curette, or a rake curette.
52. A method (200) for determining the size of a lesion during arthroscopic surgery, comprising: inserting a measuring tool into the casing through the baffle seal subassembly; extending a measuring stick from said measuring tool; measuring at least one dimension of at least one disfigurement using at least one or more markings on the ruler; retracting the ruler into the measuring tool; as well as The measurement tool is removed from the sleeve and the baffle seal subassembly.
53. A method (250) for scoring cartilage using an articulating arthroscopic cutting tool, comprising: selecting an articulating arthroscopic cutting tool based on the measured size of the defect or lesion; removing the baffle seal subassembly from the casing; inserting an articulating arthroscopic cutting tool into the cannula; Use the thumb slider to adjust the blade's bevel angle; locking the tilt angle; pressing the blade into the area of cartilage surrounding the defect; as well as The articulating arthroscopic cutting tool is removed from the sleeve.
54. A method for removing cartilage and preparing a surgical site, comprising: inserting a surgical cutting tool selected from at least one of a circular curette, a square curette, or a rake curette into the cannula and barrier seal subassembly; using the surgical cutting tool to scrape, cut, clean and remove cartilage within the area of cartilage defined by the articulating arthroscopic cutting tool; removing the cutting tool from the sleeve and the baffle seal subassembly; as well as The procedure is repeated with one or more surgical cutting tools until the cartilage within the cartilage region is completely removed.
55. A ring-shaped scraper assembly (350), comprising: Handle(352); a shaft (354) coupled to a distal end of the handle; as well as an annular curette blade (356) coupled to the distal end of the shaft, wherein the shaft (354) comprises a cylindrical rod having at least two bends (362, 364) such that the distal end of the shaft has an axis that is parallel and eccentric relative to a major longitudinal axis of the shaft, and The annular curette blade (356) includes at least one surgically sharp edge (374).
56. The annular curette assembly of claim 55, wherein the shaft (354) comprises: A cylindrical rod (358); a flat portion (360) at the proximal end of the cylindrical rod (358), the flat portion being adapted to be attached within the handle (352); a first bend (362) in the cylindrical rod (358) near the distal end of the rod such that the rod axis is inclined away from the main longitudinal axis of the cylindrical rod; a second bend (364) in the cylindrical rod (358) further toward the distal end of the rod such that the rod axis is inclined parallel to and eccentrically positioned relative to the primary longitudinal axis of the cylindrical rod; a cylindrical portion (366) of reduced diameter adjacent the distal end of the shaft; as well as A recessed opening (368) at the distal end of the shaft has a flat inner surface.
57. The annular curette assembly of claim 55, wherein the annular curette blade comprises: a ring (372) in the shape of a hollow right conical frustum; a rounded edge (370) around a larger circumference of the ring (372); a surgically sharp edge (374) around a larger circumference of the ring (372); a cylindrical connecting shaft (376) disposed radially outwardly at the outer wall of the ring (372); and a cylindrical welding shaft (378) which is coaxially arranged with the connecting shaft (376), The diameter of the cylindrical welding shaft (378) is smaller than that of the cylindrical connecting shaft (376).
58. The ring curette assembly of claim 55, wherein the shaft (354) and the ring curette blade (356) comprise stainless steel type 17-4PH (630) conforming to ASTM A564 or equivalent, UNS S17400.
59. The ring curette assembly of claim 55, wherein the handle (352) comprises: a cylindrical body (390); a plurality of ridges (392) on the outer side and bottom surfaces of the cylindrical body (390), the plurality of ridges being arranged perpendicular to the longitudinal axis of the cylindrical body (390); a flat surface (394) along a top surface of the cylindrical body; as well as A circular opening (396) is provided in the distal end of the cylindrical body.
60. The ring curette assembly of claim 55, wherein the handle (352) comprises acrylonitrile butadiene styrene (ABS) or an equivalent.
61. A square scraper assembly (400), comprising: Handle(402); a shaft (404) coupled to a distal end of the handle (402); as well as a square curette blade (406) coupled to the distal end of the shaft (404), wherein the shaft (404) comprises a cylindrical rod having at least two bends (408, 410) such that the distal end of the shaft has an axis that is parallel and eccentric relative to a main longitudinal axis of the shaft, and Wherein the square curette blade (406) includes at least two surgically sharp edges (412, 414) at a distal end of the square curette blade.
62. The square curette assembly of claim 61, wherein the square curette blade comprises: a ring (416) in the shape of a hollow rounded rectangular prism; at least two surgically sharp edges (412, 414) at the top and bottom edges of the ring (416) at the distal side of the rectangular prism; a cylindrical connecting shaft (422) disposed outwardly at the outer wall of the ring (416) and opposite the two surgically sharp edges (412, 414); and a cylindrical welding shaft (424), the cylindrical welding shaft being coaxially arranged with the connecting shaft (422), The diameter of the cylindrical welding shaft (424) is smaller than that of the connecting shaft (422).
63. The square curette assembly of claim 62, wherein the shaft and the square curette blade comprise stainless steel type 17-4PH (630) conforming to ASTM A564 or equivalent, UNS S17400.
64. A rake-shaped curette assembly (430), comprising: handle(432); a rake shaft (434) coupled to a distal end of the handle (432); as well as a rake blade (436) coupled to the distal end of the shaft (434), wherein the rake shaft (434) comprises a cylindrical rod that tapers to a smaller diameter near the distal end of the shaft (434), and Wherein the rake head blade (436) comprises a tapered wedge having at least one surgically sharp edge (454).
65. The rake curette assembly of claim 64, wherein the rake shaft (434) comprises: A cylindrical rod (440); a flat portion (442) at the proximal end of the shaft, the flat portion being adapted to attach within the handle (432); a tapered portion (444) wherein the diameter of the cylindrical rod (440) gradually decreases toward the distal end of the rake shaft (434); and A cylindrical welding shaft (446) having a further reduced diameter is disposed coaxially with the tapered portion (444) of the rake shaft (434).
66. The rake curette assembly of claim 64, wherein the rake head blade comprises: a wedge-shaped body (450) having a thickness that decreases as the depth increases; a rounded top portion (456) having a cylindrical opening (452) for welding; as well as A surgically sharp edge (454) at the end of the wedge-shaped body (450).
67. The rake curette assembly of claim 64, wherein the shaft and the rake head blade (436) comprise stainless steel type 17-4PH (630) conforming to ASTM A564 or equivalent, UNS S17400.
68. A method (460) for cutting a cell seeding support matrix, comprising: The matrix cutter size is selected to match the surgical site, which is prepared by cutting and removing the cartilage surrounding the defect or destruction; placing a cell seeding support matrix on a cutting mat with cells on the matrix facing upward; placing the selected matrix cutter with the surgically sharp edge facing downward onto the cell seeding support matrix; applying a downward force on a top side of the matrix cutter using at least one of a hand, a mallet, a hammer, or other tool; as well as The matrix cutter is removed and the uncut portion of the cell seeding support matrix is removed.
69. A matrix cutter comprising: An elliptical cylindrical body (502); an inner bore (504) shaped as a stadium-shaped hole aligned parallel to the semi-major axis of the elliptical cylinder body (502) and longitudinally aligned parallel to the longitudinal axis of the elliptical cylinder body (502); a flat top surface (506) of the elliptical cylindrical body; at least two flat gripping notches (508) at opposite outer sides of the elliptical cylindrical body; as well as A surgically sharp edge (510) is provided around the bottom circumference of the elliptical cylindrical body (502).
70. The matrix cutter of claim 69, wherein the matrix cutter comprises stainless steel type 17-4PH (630) conforming to ASTM A564, UNS S17400.
71. A method (520) for delivering and implanting a cell-seeded support matrix into a prepared cartilage surgical site, comprising: stopping the fluid flow and removing the barrier seal subassembly from the surgical site; using a first swab to clean and dry the surgical site where cartilage surrounding the lesion or defect was previously cut and removed; Using forceps, grab a piece of previously cut cell seeding support matrix by grasping the edges of the matrix; The delivery tip of the trans-matrix shuttle delivery device places the cell seeding support matrix so that the matrix is located within the contour at the delivery tip and the cell-containing side of the matrix faces away from the delivery tip; Applying fibrin glue to the surgical site using a second application swab; inserting the matrix shuttle delivery device into a cannula at the surgical site; Depressing a plunger on the matrix shuttle device to extend at least one antenna from the delivery tip of the matrix shuttle device to push the cell seeding support matrix out and onto the surgical site; removing the matrix shuttle device from the cannula; If necessary, use a third swab to reposition the cell seeding support matrix; as well as A fourth application swab was used to apply fibrin glue around the edges of the cell seeding support matrix at the surgical site.
72. A smearing tool (580), comprising: Cylindrical rod (582); an applicator swab (584) attached to one end of the cylindrical rod (582) by an adhesive; as well as an application tip (586) attached to the other end of the cylindrical rod (582) by an adhesive, wherein the cylindrical rod (582) comprises a plastic material; The swab (584) comprises cotton, polyurethane foam or other similar soft absorbent material, and The application tip (586) comprises soft silicone or other similar compliant material.
